Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Yersinia pestis CO92, CO92

>YPO3615 hypothetical protein
MTVAQSIGTGYGAAGAQSALRQTALGQQSPARTDYQVSNPNVGNIARASD
SLLNVAESQQFNTLVTAGFGMQAIAAGVAGGYVGAKIGNKLGHGIARALN
FNQVATEGESPAHLGHPIAHQKKDWGVWGAIGGILLGAAAAALVVVTFGT
GLVVIAAAAAAAGLIGGIAAATGAALGQYGDNKGVIAEGSANVFFEGQPV
ARVGDKIQCSDHPSSPPPMIAEGAKTVFANQKQIARLGHRTTCDGNINAG
CGSLAITQETAYVYEVADSRNPYLRWSAVILSFLPIQKKFEQGFRSLKKP
PNTAVNATHNCPTGSDPVDMVSGDYLQVWPVIDIAGVLPVRLQRTYRSGD
YFTVSGCFGHKWADSWSQHLVVHEDNIDYIDEEGVGLSFFTPENKVQAVN
LYNLRYELVGERHGELRVFDRSTQQTLHFNQQQQQQRYLSAITDRKGNRI
DFRYQQGELISVEHSDGYVLEIDSRGRTIHAVELVTQEKRQKLLQSTFSE
RGYLVQCQSFQYGTLSHEYDPKGYMVRWRDTDSTDVAVRYDISGRVVALK
TSTGFFADHFIYHDKERYTIYRDGEGGETGYHYNENNLLIKLVDPLGNTT
LTDWDLTQKIKETDALGRITRFIYNERGDLTAVILPDETRTEYEYNPSGV
VTAFTSSAGDSWQYQYDRQGLLRQVTYPSGQTMSFRYGKKGEVLRKIIAE
DQVWRYHYDHHGCLSTIIDPKGNSTAVTLDVLGRLFSHQNALGELTRYTH
SDAHASPAGSVTKMVMPDGVEQAIAYDSEKRIAALTDGAGKTTRYEYGGF
DLLTGLIRPDGQRLTFGYDTLTRLNQVTNASGDTYRYTRDRAGQVISETD
FTGRTVHYQYDAVGRRIGARYPDQRLVRWHYSMQDQVLAQQTWHCDALSS
TLVGTVSYGYDGAGRLLSATNADAVVEFDYDEAGQLVAERLNGREVRHQW
DALNGTPVARQVGELGLTFVYGAQGELTRLQLAGHQPLQLQHDRLGRETV
RESAAGFIQACNYTPSGLLAHQAAGRNSALFQQQLIAPESPALHGSAVNR
SWQYDRAYNVVGMDDGRWGKTQYQYDRNDQVVRADFGGFLPLQEQFSYDV
NQNLREHRCLPRGAQAVLAQASQQQQAGRVVKRGDSQYRYDAAGRLVEKR
SQKDGYRPQLWRYRWNEQDQLSELITPTGARWRYGYDAFGRRIRKLRVVD
TPPLNEMDAPSTGPATASLAGYAYLWSGDQLIEEVPVYADGTVAYEQGIH
WLYAPGGLTPMARYAQGKLHYVVADHLGTPRELLNEQGKVVWASRLSTWG
QAELWRQAANEEDRVSCNLRFAGQYADAESGLHYNRFRYYDGETGQYLCP
DPIGLEGGLNPYGYVHNPVSWVDPLGLATCPMREVNGTKIFGKGQKDGTP
GHDQFSEVIANKLAMSGKFKEVYLNRSYNFANGKGISGRRPDIMAVDMNG
KVHAIELASKTDMGRKFPSLRTRNQDAMKNLPSIDRGSVIVLEHQYNSSK
IKNALDNLISGI
>YPO2341 putative mandelate racemase / muconate lactonizing protein
MRTVRFYPEAWPLHSAFVISRGSRTEAKVIVVEIEENDIHAFGECTPYPH
YGESESSVMAQLALVANAIENGVSREALQPLLPAGAARNAVDSALWQLEC
LQHQQSLWQRSQITAVETVAMAQTVSIGTPEAMACSAKALVQLGAHLLKV
KLDEHLIAERLVAIRSAVPEVTLIVDANEAWQPEGLAARCQLLADLGVVM
LEQPLPAGEDSSLQNFIHPLPLCADESCHTRADLAGLVGRYDMVNIKLDK
SGGLTEALLLAEQAKSMGFAIMLGCMLCTSRAIRAALPLAPGARFIDLDG
PTWLANDVEGGLHFSTGTIDLRVR
>YPO3608 hypothetical protein
MFEAARVDDKLYHSSALAGFIIGSIIGAAVIFAAAAYAASIVLTGGATLV
ATGFIVGMGVTTLGVVAGGLIRSVGEKIGSMCHHDVGQITTGSKNVKVNS
KRAAHVELSTVACKDDSAIQRMAEGSSNIFINSKAAVRLEDKTTCDAVVD
SASSNVTFGGGRVQYLDIKREISDEMRDLSEKLFIVAGLAGGIFGAAKQA
GCFGLKCLSKIALGEMAGAAAGYGLEKGVGAIAGYFGYPVDVISGQKLLT
GEGDDTDFILPGIFPLHWSRIYRSENHHVGALGQGWSLVWERSLRKEDDS
IVYQNDEGREIVFPLIKRGERYFSPTEHIWLARTERDTYAISSPFETCFI
FEAFSEAGVAKLASLEDLNGHALYFSYDDIGQLKKISTTSGYGVYCQYEK
GRLVSVACVKGGTPGTLVRYQYNEQHQLVSVTNREGQITRQFGYHGHLIN
KLADVRGLECRYTWADIGGTPRITHSATNLGEQWQFDYDIDNQQTTLTDL
NTGQTACWGYNAQHLITDYRDFDGGKYAFDYNDLNMPVRVVLAGERTLVL
VYDALARPIQITDPLKRETHIDYHRNSLRVVRRQYPDGQVWKGEYDRTGR
LLKENAPDGGVTLYHYPGASSLPERITNAVGAQTHLGWERHGQLTEHTDC
SGKLTRYEYDIDGHLLTVIDAENHSTHYSYNRLGQPTGIRYADGRKEQLR
YNAQGLVEQFTDPVGRQLHWRYNLRGQPVSFTDRLQREYRYRYDCHGQMI
ELDNANGGQYHFRWSSGGQLVEEQYPDNLVRRYRYGESGMLMALETTAPT
VDDLTVSRQVSFDYDAGGRMTQRLTGMSATRYDWDIMDRLLLAERVPTAV
GEQAGIVGHGVRLAYDKAGHLLTESGDLGAVTYQWDPLHHLAALTLPDGQ
TLSWLRYGAGHVSAIRHGDTLISEFSRDNLHREVSRTQGILTQYRDYDAM
GRRL
>YPO2073 putative lipoprotein
MTQSKKFRNHKWMYGWLGLGALLLSGCVTIPPAIQGTTATPLQDLNLIRS
APKLFIGQEARFGGTVVNVKNEPNRTRLEIASVPLDSGARPILGEPSQGR
VIAYVDGFLEPVDFRGHLVTVVGPIVGVEAGKIGMTPYNFVVIKATGYKR
WHIAQQVIIPPTFGPWGYRPADMWGPGWPGWYNPGPAEIQTIVTD
>YPO1513 hypothetical protein
MISNLWWSLPLTLIVFFGARQLSRWAKIPLLNPLLISMVVIIPLLLVTHM
PYANYFAGSKILNDLLQPAVVALAFPLYEQLHQIRASWKSIIAICFIGSI
TAMVSGTAIALWMGATPEIAASILPKSVTTPIAMAVAESLHGLPAISAVC
VIFAGILGAVFGHSLLNLLKITTKASRGLAMGTASHALGTARCAELDFKE
GAFSSLALVICGIITSLLAPFLFPVLLHLFG
>YPO1645 hypothetical protein
MIAVTGATGQLGRLVINVLLKKVPAHDIIAAVRSPDKAKDLMALGVQVRQ
ADYNQPTTLDSAFKGVDKLLLISSSEVGQRVAQHTAVINAAKRAGVKLLA
YTSLLHADKSPLGLGEEHRATEGLLRDSGLPVVLLRNGWYTENYAASIAP
ALAHGAFIGAAGNGRIASASREDYAEAAATVLVQENQAGKIYVLAGDDAY
TLSEFSAEITRQSGKAVAYQDLSEADFKHALISAGLPDGLAGMLADSDAG
AAQGGLFDDSHTLSKLIGRPTTPYAKVITATLATR
>YPO0617 hypothetical protein
MMTHAVLTARIAKISLTCSILSWSLLIVGCATDRLDLAPASYTEPWTPDG
NARASMGGGNFSVPPNPIVAELAQPPTIKSDHAYSLPELIDIAQRQNPDT
RIAWQQARQAALAVGMGEAIFLPIISASVIGGYQRTTTPLPYAIGNEKDL
KTTGSAVIPALALQWLIFDFGQRSALLDAAKQTSYAANVTFNGMHQKLIY
DVTRTYFQYGAAQAQSQIAKQTLQNSLKIQDAAEERQKKGIATTVEVALA
RQQVAQSQLRRVVAKGTERDAYQALLGAMGVSPSLDIKAAYTEDRALPDG
ISAPTEKMIQLALSQRPDVLASYAAVEAAKAGIKATEADFLPKVYLAGAV
AGGDGHFDIQGLPGISPQTSSSSILVGVSVPLYDGGIRAARVKEAESRAA
VAAEGFKKTQELAVREIVVAADTLRSALESNQAALNLVKTSFISYDAALE
SYRSGVGTITVANEAANGLLNAQQMSTDAHAASLVAAANLAFVMGKMTNT
SPPLELLH
>YPO1498 hypothetical protein
MDIKLEKKININSREKIVILFVLLILFLSCFFIYYLFTKESALLVPRERA
IFYTAQFEPYQDVLVTRAITVPNESVILSSERGGKIIEIVKQSAENVIKG
DVIARLSNYDFTLEATSRMADIMEQINSLRNMRMRLEQDSRDTQLSLQEA
QHQIDIISKDLRRYKILDKKFLIAKSELERQADRLINWKVKSDILQKHNS
RNQKSFPSQFKNIDESIILLEKMMKMIEVGIEQLVIIAPIDGTLSVLDIE
LGQQIKSGEKISVIDNLNSYYFNVYFSEYYIDKIKPNTQIIAQINGQDTQ
LLIESVSAIVDNGKFKAKLRPIESGIAHLKRGQSIEIRIALQEENNHVLL
VPTESVFSNSNGDHFIYIYQDKYDRAIKTKVEVKRRNSIKTEITSGLQPS
QRIVKMPDDSDKTANIIEFK
>YPO2081 putative lipoprotein
MKGSVTAVILATAISFGCVSKNAKALVAGGTSPRSTSKSMLTPGATASST
PTMLSQQGRDPSQFPAYVEQLKAQARAKGYTTETLDTAFANIHFVDRVIK
SDRNQLEKKITLDDYLTRVLPRKRIEQGRALYQRYQPQLSQVNAQYGVPG
RYIVALWGMESAFGQIQGKEDVISALSTLAFEGRREAFFTKELMAALEII
HQGKVDDPQLRGSWAGAMGQSQFMPSSFLTYGADGDSDGKIDIWNNIDDV
FASTANYLSTQGWKSEQGWGQEVTLPQDFNVKLAGLDDGQAKSIAQWQKL
GITPVQNAHFAESAARVWVIIPDDLKGRAFLVYDNFRTIMHWNRSYYFAI
SIGMMADSIGQ
>YPO2438 putative membrane-bound lytic murein transglycosylase
MNSKVGCLMAILLLAGCAKQTPPPQANNGWLKKTPQGNSLNVAKSSAGST
TVAYSDVIKQAASHYGVDETLIKAIIQVESGYNPDVVSRSNAVGLMQIKA
STAGRDAYRMKGRNGQPSSRELKDPVKNIDIGAAYINILQNQQLAGINDP
QTLRYATIVSYANGAGAMLRTFSSDKRLAVNKINSLSPNEFYQHIQKKHP
AAQAPRYLWKVDTAYRAMSE
>YPO2422 conserved hypothteical protein
MQSFLPFSRPAIGSEEINAVANVLGSGWITTGPQNHQLETDFCQIFGCKH
AIAVCSATAGMHITLLALGIGPGDEVITPSQTWVSTINMIVLLGAEPVMV
DVDRDTLMVNAAAIEAAITPNTKAIIPVHYAGAPCDLDALRQISQRHGIP
LIEDAAHAVGTRYRDQWIGEQGTAIFSFHAIKNITCAEGGLVATDDDELA
ARVRRLKFHGLGVDAFDRQIQGRSPQAEVVEPGYKYNLSDIHAAIAVVQL
RRLPEINARRQALVASYHKALAHLPLQPLALPHYSHQHAWHLFMVRVDEE
RCGISRDQLMACLKDMGIGSGLHFRAVHSQKYYRERYPHLCLPNTEWNSA
RLCTLPLFPDMLDSDIERVANALTTIIGSHRVTK
>YPO2953 hypothetical protein
MFKVKLNKTLSLLWLAAVGALLVSVNFKGNALWNNVIFITFLALMVLAIW
KHYALKPKHPQVSTPIPQETAEPVEQESTVILILGPYAEKWFSNPESPDS
TRFSSHAVWILITNPAALQKRLTYIAEHHPSARVLTFFPFLPDVYENAAV
MMSKLTVWQNTFSTLSLRSPLPCVFAIYAQLSNERLSHNSDNAYWTGNIN
LANQQPIEITQALQSLSQRLELQDINHSRFATQRNVMAHNLFTWLNESGV
TNLLQSIFSRTPLRLTDVILSDNGKGFIRHGAWSAWLEKKFGIIPSLAST
LSLPPFPAVINDQKPAMKPRVKTPVIKPTPASRGWLWSVCFAAVLLASHM
LNTLWQEKNRHEQFNQQMVPLDNISDFSAQYLARSITQLTDEGKILTTCV
NTFDVTRWGLSQCKTLLSQINRRIESYENIPVFSFAQKLPLFDSNSTKLK
LNSQTNEMMMELLSLVERNKEKKILIVGHSDNTGSSSMNMALSEQRALAL
RDWLIKRSDITVDNFITKGMGASEPVATNHTEAGREQNRRVEVLILPTQD
RTRMTEPKPL
>YPO1559 hypothetical protein
MTKNKTGSETLKKLLLTGATGFLGGAVLEKLLLASSDFNYLLLVRANTPE
QGLMRIRENLEKFYLPNELINKININHVLLGDLAEPDSFINDVRIDDVTH
VINCAAIASFGNNPLIWKVNVEGTLAFGKRMAQVAGLQRFVHVGTAMACT
PEADTVVDERVLSTENDAHLVEYTKSKSAIECLLAEHCPTLPLVFARPSI
VVGHTRLGCQPSSSIFWVFRMALMLRKFMCSLDDHIDVIPVDYCADALLY
ILEYPNLPDDIYHISAGEKGSVSFSEIDQAMSVAAKQKPVGVNYSQVEYT
ALVQMRNQLKGIFGPCNERLMLKAMRLYGSFAMLNVRFSNERLLSLGMPR
TPRFTDYIARCVESSHGMTIQQQMAVDFK
>YPO3028 putative autotransporter
MNTNSKKTYLNIAISFILYASTAMNANADSCIDYTVTDICEQSKYAAGEF
HNIKLGDGVTAGSEDHHFVFNGEGYELYNSNANFSAQIASGTIRYTEVNN
SYFTVNAHHFPDDTIYAGRAENTTLNDSLMWVATSADQTLAKGNSMVVVS
TQMAMVDQIFVTTLNDGSLPFDPVITNSRYEDTSYEMLWGMKNEAKGWDT
KATSHDSVFVDASKQSIEANGHSIGATFYGRATQVVKAGGESQDTHLFDH
SYSWVYAEAKLTGLTEVNDAATVYLNAAATQGAYAENVVLNGEDTTLMVR
ASLDNNAYATVDNLILNGGEVVFQQSSGDQYASLNIGTLSGSGSFLFNTS
IAEGKGNFVTIANASGEHKVIVNDSGHEITSPDMTTLDLIHDLSGDATFT
LASISGANIIEVDGGTYVYSLNTWDNSARAGGNLWYLGSGLNTGTELEPE
PEEKTTPSTDAVLSMASSNQFIFDGEMQNLRFRKGDLNNNKGDGASVWGR
YLTNNTRVNAAHDAAYRLQQDGFEIGADKVLEMSSGQLVLGGFTSYSNNR
VKHARGGNSTVDSYSLGAYGTYFDNSGYYVDAVVKANRFKNSLNAHMTNG
GSVQSDYNQNAIGGSLEAGYHYSLSNNWFVEPYVRTSYYTAQDKDIALNN
GMTANIDNNRSAKGEIGTHLGTKIDLNNGAIIRPYAKVAIEREFIKSNTV
TINQVNDFNNDLSGHTAKYGLGMDINLMKQTSVYAEANYRNGTHVESPIM
ANIGFRINF
>YPO2847 putitive HlyD family secretion protein
MKSQSKRTSRLFVFVGVVVAIIIAVLSWRYFGTGSDNNTSGAQQSARGQD
TSHGGRRNTPLAPVQAATATEQEVPRYLTGLGTVIAANTVTVTSRVDGEL
MALHFTEGQQVKAGDLLAEIDPRPYEVQLTQAQGQLAKDQATLDNARRDL
ARYQKLSKTGLISQQELDTQSSLVRQSEGSVKADQGAIDSAKLQLTYSRI
TAPISGRVGLKQVDVGNYITSGTATPIVVITQTHPVDVVFTLPESDIPAI
IQAQKNAEKTHAIVPVEAWDRTNKQMLAQGYLLSIDNQIDTTTGTIKLKA
RFNNEDDVLFPNQFVNARIKVDLLQNAVVVPTAAVQMGSEGNFVWTLDDA
NKVSKHLVTTGIQNSQQVVIDAGLNAGQRVVTDGIDRLTEGVQVEVVTPR
SANTDANPASAEKAAAEAEGSTPHQGRGRPANAPARSTTAAEKS
>YPO2972 putative lipoprotein
MKRKIFLSTMFITAFLLSGCATESSRSLEVAKVASYGTQYNGPRSPISVG
KFDNRSSYMSGLFSDGVDRLGNQSKTILVTHLQQTGRFNVLERTNMEELK
NEAAISGKSQRLKGATYVVTGDVTEFGRKETGDRQLWGILGRGKSQVAYA
KVNLNIVNVNTSEVVFSSQGAGEYELSNREVIGFGGTASYDSTLNGKVLD
LAIREAVNNLVAGIESGAWQPAQ
>YPO2999 putative HlyD family secretion protein
MQHVTGSKRRLIGWVVLLLIIGGLLFFRWISPPDKPSYITAVAEIRDLEQ
TVLADGTIKAQKQVTVGAQVSGQIKALHVTLGQQVEKNQLVAEIDDLAQQ
NALKDAEEALKNVQAQRAAKIATQKNNQLTYQRQQQILAKGVGVRADFDS
IKATLEATQAEISALDAQIAQAEIAVSTAKLNLGYTKISSPIAGTVVAIP
VEEGQTVNAVQSAPTIIKVAQLDTMTVEAQISEADVVKVKTGMPVYFTIL
GEPEKRFSATLRAIEPAPDSINDETTTTSSSTSSSSSSSTAIYYNGLFDV
ANPTGALRISMTAQVYILLNQAKNAVVIPATALENDQGQYRVQVVDNSGK
VSQRTVTVGLNNNVDAQILTGLQAGEHVIVSQGSTTSTNSKAPRMGPPMG
M
>YPO3918 hypothetical protein
MNRLQQSSDKLIFWLVGALLACGIHIYALWWLSTASIPAIPTSYPAAIMM
ELSAEPEFMQNLPQNSVVGITQNIIEPAVEQRVNQPDDIVDLPTLPEQPE
GQREITRKEPIKVKRPAENRATSRKPVNKETQESDSKQSSPAAAASAMLS
GTSQQVAAAVNSDSSHRQQAQVSWKSRLQGHLMGFKRYPSSARKQQQQGT
AMIRFVVDKNGYVSSVQLSHSSGTSALDREALAIIKRAQPLPKPPAELLS
QGQITLSLPVDFNLKRK
>YPO1628 lipoprotein releasing system, transmembrane protein
MMGVSPLSLLIGLRFSRGRRRGGMVSLISVISTLGIALGVAVLIVGLSAM
NGFERELKNRILAVVPHGEIAVVNQPFSGWPQTLQRIEKVPGIVAAAPYI
NFTGLIENSTQLRAVQVKGVDPEAEQHLSALPSFVLDNAWSHFKAGQQQI
ILGKGLADTLGVKQGDWLTVMIPNSDPEMKLLQPKRIRLQVAGIFQLSGQ
LDHSLALVPLIDAQQYLDMGDSVTGIAIKVNDVYNANQLVRNAGEVSNAY
VYISSWIGTYGYMYRDIQMIRTIMYLAMVLVIGVASFNIVSTLVMAVKDK
SSDIAVLRTLGAKDGLIRAIFIWYGLLAGLIGSISGAVIGVIVSLQLTTI
IRGLEKMVGHQFLSSDIYFIDFLPSELRWFDVACVLATALVLSLIASWYP
ARRASRIDPARVLSGQ
>YPO2123 putative phage minor tail protein
MRDKTLKAILAHAEAEHPKECCGVVAQKSRVEKYFPCENLATNPTEQFHL
DPTGYVEAEDWGTITAIVHSHPDATTQPSELDMAQCDNNELPWHIVSWPE
GDLRTIQPRGDLPLVGREFVLGHTDCWGLIMSYFRQTHDIELKDYRVDRH
WWESGTENFYMDNWYECGFREFSGPAQPGDLIIMQVSAPVANHGGILLED
GMLLHHPYGQLSQRVPYGGYWQERTMKVVRYEISQL
>YPO1614 hypothetical protein
MKTADCHISPVSGLTGESWRITGPGIDWLAREQSPHKSQLGVNRRRERKF
LQHIAGNGLSPAVIAANQRWLVVNWLEGDVVTNEQFIPLVNHGQLARLLA
RLHHLPASGYRLDLRAQIARYGALIDPTRRSPGGVRLQHDFLRRPLPAIT
KIAPLHMDIHPGNLLTTPVGLKLIDWEYAADGDIALEIAALFRGNHWSML
QQQAFLQDYCNNEHGYHDIARLSRQIQQWLPWVDYLMLMWFEVRWQQTAD
PIFLAWAAPLRQRFNLSF
>YPO2174 putative nucleotide sugar dehydrogenase
MKVTVFGIGYVGLVQATVLAEVGHDVLCIDIDANKVADLKKGRIAIFEPG
LAPLVKENYEAGRLQFSTDAQAGVAHGVIQFIAVGTPPDEDGAADLKYVL
DVASTIGTYMDSPKVIIDKSTVPVGTADKVHQVIQAILEQRGEKIDFSVV
SNPEFLKEGAAVADCKRPERIVIGIDTDDSGALELISELYEPFNRNHDRM
LVMDIRSAELTKYAANGMLATKISFMNEIANIAERLGADIEKVRQGIGSD
SRIGYHFIYSGCGYGGSCFPKDIQALIRTAEDKGYKPQLLQAVEQINNQQ
KYKLTEFIKSHFNSQLAGKTFAVWGLAFKPNTDDMREAPSRVVMESLWEA
GATIQAYDPEAMDETQRIYGARDDLRLMGTKESALQGADALIICTEWQSF
RAPDFDMIKSRLKHPVIFDGRNLYDPERLNSRGFTYYGIGRGVSINLS
>YPO2470 hypothetical protein
MMQQRISQWLERLGMEFSDVMSLTMVIGLILLISVMIHLVLHRVVLAALQ
RRGQQSQRIWQQAITKHKLFQRVALLLQGIIINLQAVLWLQNGSQTQAVI
VTAAQVWIMAFALLALFSLLDTLLALLRQSSVAHQLPLRGICQGLKLVAA
IFIGIMIVSLLMGRSPLLLLSGLGAMTAVLMLVFKDPILGLVAGIQLSAN
DMLKIGDWLEMPKYGADGAVTDIGLTTVKVRNWDNTVTTIPTYALISDSF
KNWRSMSESGGRRIKRSINIDTTSVHFLSEQEQQRLTLNPLLQHYLSEKS
QELNQYNQQIALDLSSPLNGRRLTNIGTLRAYLVAYLRAHLGIHQSMTLM
VRQLAPTPEGLPLEVYAFTNTTIWAEYEGIQADIFDHIFAVVSEFDLRIH
QTPSGNDMRSMLAKV
>YPO1626 lipoprotein releasing system, transmembrane protein
MYQPVALFIGLRYMRGRASDRFGRFVSWLSTIGITLGVMALITVLSVMNG
FERNLQDTILGLMPQALITTPQGSLDPNKIPASTLKSLSGVSDIVPLTTA
DVVLQSARNLAAGVMLGVDPQQHEPLANYLVNVDIKALAPGSYNIILGEK
LAGQLGVKRGETLRLMVPSASQFTPMGRIPSQRVFNIIGTFAANSEVDGY
QILVNQQDASRLMRYPLGNITGWRLFLSQPLSVDSLSQQSLPEGTVWKDW
RDRKGELFQAVRMEKNMMGLLLSLIIAVAAFNIITSLGLLVMEKQGEVAI
LQTQGLSRRQIMLVFMVQGATAGVIGALLGAGLGVLLASQLNTLIPILGV
LIDGATLPVEIDPLQVTVIALLAMVIALLSTLYPSWRAAAAQPAEALRYE
>YPO0762 hypothetical protein
MAMPAVKHFDPVIGLDVHTVIIPPSPAPIPIPHPHVGFVLDLRECVNGVK
SVVGSIVFSFAAEAAADVMEDNPELLAAGMALVSKAGSALEAAANNPVVK
TGLALKDAKDQLSGLKAGIIDTLGGNIGGGGGSNRPVKVNGTLRSTVGTH
TFHIPGLHFPLGTLFAPLIPSKDSESFMGSKTVMANGDPLSYMALPAMSC
WFVGLPSTPKNAAHTQRKSLSLPTSVMLPIPMGRPVVVGGMPVLNLLALM
MGLFKIFRGSKLAKKLAEKLGLKSGFLKCTILDAEPVNSITGEVVVEQND
FVVEGRFPLVWDRYYGSQKAVTGVIGQRWQCPADIRLEVLVDQGELGVVA
RFPDHETVFSLMPIEQGWDERVYDWQQGHALYRSGNQLVLRTRHEEEYFF
TLPNDWESTVIPFTAADRLTLPILRMADRYGNGWQFKRQGNSLLLALIEL
TQGLLSGREVHVIQDENAPISGMLNDFVLVNKTNGERRFLVGYRHDGEGN
LIATLDADNHPYQFEYIADSQMVRHTDRNGLSFYYRYQRHSDGLDRVEHA
WGDGGLFDYRFHYDRVYQETQITDSLGHTTLLRYDERGLPFARVTPLGGV
YSYQYDAQCRTIAEIDPAGNTHGWMYDQYANLTEETFADRSSVKTEYGDD
HKPVRITDPGGRFWRQSWDAQGKVISQTTPGKIATHFTYDDLGQLVAVVD
ASQQRTELAYDAWGFLRVITDARGNATSFKHDFCGNLLKKVAANGDITRY
QYDKKQRLTGCTLPDARTIRCEYDREDNLLLYNENGSRITRFGYFGQGRL
QSRTDPDGSLTEYLYDTEEQLIGVKNQRGKTWQLKRNAEGRLIEEVDYWG
QSRRYQYNAVGHLTGSHDPLGQILAVTCDKLGRITEKNIAGDEQAWERYE
YNVQGQLIGAVNPAVTVTRRYNQDGQLAQEIQQQPQVSATVEYGYNAAGQ
QVEQRHLLQYADEDDIQVQQRIRYGYDVLGQCISQQIDDHRPMAFSYDKI
GRLTEQRLTPSLSHHLRYSAAGQLAGYQTRRKGMVWSETDYFYDQHGNLT
QREDSRQGSERYHYDVLGQIVGYQDPLGTLHRYRYDACGDRFSTVADNAE
GRHTQQDNGTAYQLDKAGQLVSRTDRFSQLALRWNTFGRLAGIKNEHHDH
AYTYDALGRRVGKRHLQRPTKLLDGLRVIDKETPSRGEPVWQDETWFMWD
GDVMVGELQREVAPRVVTPETWDKPDGIVYSGQFYVYQPDSFEPRAMQRY
QQIAEAEDGEIAPLGEEQIYFYQNDPNGMPIRLQDGEGEVVWEAQFTPFG
QLSVTGTSQLRQPLRMQGQYYDTESGLHYNRYRYYDPACGVFISQDPIGL
KGGLNPYQFAVNTLGWVDPLGLWKKRRNNGQFAKKPGRKKTNLVIQHMEI
AMILINQQKGILCVIVISVMLRNMVKQLKVRRDTLRSI
>YPO0448 putative lipoprotein
MQKMQNKRLIQRIWVSFLAMGLMLLVGCQAKPQGLTPDQIAALQEQGFKL
TDNGWEFGLANKVLFDSDVKKLNSEGMQTVQKIGRILSDVGIKHMRVDGH
TDSVGKDDYNQQLSYQRALAVADTLATVGIPKSNIDVRGRGKLEPVADNR
TSKGRAENRRVAIIITAS
>YPO1979 putative dehydrogenase
MKVLVTGATSGLGRNAAQWLLEAGHEVYAIGRDQLAGEELRKLGATFIPL
DLTMTTMEVCQQWLKTCDVVWHCAAKSAPWGNPQDFHQTNVVVTHKLAQA
AGREGVKRFIHISSPAVYFDFRHHHDLPETYRASRFSSHYASSKYAAEQV
LHECIAHYPDTTYVILRPRGLFGPHDRVIVPRLLQQLSRDRNVLRLPGGG
QAQLDLTFVLNVVHAMMLATDNDGLRSGAIYNITNQEPQRLVTMLDSLLN
QQLHINYTLQPVPYSLLSVVAAGMELVASMTQKEPLLTRYSVGAVYFDMT
LNSERAINELGYRPRYSMAEGIVLAGEWLSAQRSGQHG
>YPO2758 putative aspartate/glutamate racemase
MMKILGLIGGMSWESTIPYYRMINQHVKAQLGGLHSAKIILYSVDFHEIE
QLQAKGDWQTAAQLLSNAAISLKHAGAEVIVVCTNTMHKVADDIEAACGL
PLLHIADATAVQIKQQGIDKIGLLGTRYTMEQGFYRGRLTEKHGIEVITP
DDTDREAVNRIIYEELCLGIISETSRDAYRRVIKKLEAQGVQGIIFGCTE
ITLLVNAQDASVPVFDTTAIHASAAADYALQ
>YPO3163 hypothetical protein
MRKILIGTAALATVTLAPSVQAEYQWGFGNVSLNYLDWTRSTTHKSGDSS
HKDDFAYIELEGGAGFSWGEVYGFFDLENPFNSKTAQPGDNQRYTFKTTG
RYYLGDSGFNLYGHVYGTYSLPGDNRNFHEVNTLYGIGYNAAFDALWLKP
FVALHYVDQTYYSGNNGYVVGWVAGYDFTAFDEKFSITNWNELEFNRAEA
YAAGNGGKNGINGAIALWWTPVKPLTTGIQYRYAYKKLGEDFLQDGIVYS
IKYNF
>YPO0363 putative membrane transport protein
MLRSSYVRPIISWSFGLLLSFFLLMPLHAATQPNEEQVRQELKLAESNKT
TPNQAEIVQALQGALSWLADAKESDIRAQQYQKAIDDFPKLTRELRQQLA
QEGDKPLPVPSNLSTSDLEQQVLQVSSQLLELNRLSQQEQDRAREISESL
GQLPQQQSEARRMLAEIGPRIQSQSNPSTPVAQAQLTLLQAEAVARKAKV
NELELSQLSANNRQELSRLQVELYKKREARVQAQLQSLRNNLNNQRQQAA
EQALERTELLAEQGGDLPESITQQLQRNRELSQALNQQVQRIDLISSQQR
QAVAQTQQVRQALNTIREQAQWLGVSTALGETLRAQVARLPEMPKSQQLD
RDMAQLRVQRLQYEDMLEKLQQQKTTLKQDDGTPLTPDQQRILDAQWRTQ
SELLNSLLSGYDTQILELTKLKVANSQLVDALNGVREATHRYLFWVADVS
PISLSYPLAVAQDLTRLLSLDTLSQLSGAFVMMMTNQETLLPIIAALLFV
GFSVSSRRHYHAFLERASSRVGKVTQDHFSLTLRTVFWSILMALPLPVLW
AALGYGLQNAWSYPMAIAIGNAVTATVPVLWVFMISASFAHPHGLFITHF
RWSPTQVARAMRFYRLSVWLIVPLMMALITFENYNDREFAGTLGRLCFIL
LCIALSLVTNSLKRAGIPLYLDKKGSGENMINVALWGLLLSAPLIAALAS
ALGYLTTSQALLARLETSVAIWFFLLVVYHIIRHWMLIQRRRIAFDRAKQ
RRADILAQRARGEEDSPHSNSTEGSIDVEEPIIDLDVISAQSLRLVRSIL
TMIALVSVIVLWSEIHSAFGFLENIRLWDVSSTINGIESVQPITMGSLLI
AVLVLIITAQLVRNLPALLELALLQHLDLTPGTGYAISTITKYLVILFGG
LLGFSLLGIEWAKFQWLVAALGLGLGFGLQEIFANFVSGLIILFEKPIRI
GDTVTIRDLTGSVTKINTRATTISDWDRKEIIVPNKAFITEQFINWSLSD
SITRVVLTVPAPAETSSEEVTNVLMTAAQRCTLVLDTPPPEVYLVDLQQG
IQIFELRIYAAEMGHRMPLRHEIHQLILAGYREHGITLPFPPFQARLETL
GRGTGRTISSGRSRTPGSL
>YPO3799 hypothetical protein
MKYLYSILSIALLLAPGSATHGQLLATPTRIAVEAQELKRTVQVYNSGDT
PLYLDITLQRVDNPGVNPERKTPISEISQPEMIFNPNRITLGPRQKRDIT
LIPLKSPVQETLYRLYINPVLNIKAVGDGEDKSKVHAPMTISIGYGVLIH
HLPPAAAQTRHWQHQCSTTGELTLTATGTVHSKFKQLESGGNAALADSLN
LYPGTALTLPVKQLNGEVDGEKFSLRCH
>YPO1551 hypothetical protein
MKKVAIIGLGWLGMPLAQSLSRRGIDVVGSKTTPDGVDAARMSGINCYPL
VLTPELICEPDDLAQLMAVDALVITLPASRTTAGGDHYFQAVQQVVDSAL
AFGVPRIIFTSSTSVYGETRGRIKESSPLQPVTVAGKTLMALEQWLHQLP
HTSVDILRLAGLVGTDRHPGRFLAGKTGVKGGSQGVNLVHQEDVIAAIEL
LLNRPKGGHLYNLCAPIHPRKRDFYPACARALQLTPPEFAVEEQEGANRE
IDGSKICSELGFEYLYPDPSRMPLN
>YPO3638 putative phosphosugar isomerase/binding protein
MSQNKEWLAASDAWMIYSRELAALKENVDQQVWLQVLDALAECRGKIAVT
GVGTSGIAARKVAHMLACVEQPAIYLNATDAAHGDLGFLGAQDIIILISR
GGNSDELTRLLPTLQRKQVKIISVTENEQSAIAQVSALVLKTHVKQEIDP
LNMLATTSIVLVLALFDAICACLMARTGFSKETLLAVHPGGDVGMVLRKQ
Q
>YPO0417 putative O-antigen biosynthesis protein
MTTLSPAIPVNRRSEMLCSIAALLLGISMPTNNQLMSVSLVLIIISLIIN
RKSLDFKPLLTSPLVYLPAAMFVLLALSLLYQNNSYGPDMVGKYKKLLYI
LPLALFFMNQPRLIKLFCTGFLVANAVILAGSLAVGVLHIPLSGVDPTNP
TIFKLQITQNFFMALAALLWLVLAFQHQGWKRWGYSVLVVAASYSILFLV
LGRTGYVALIVGLGVWLFFSLGNRQRLTLVVLGALAFAALIFIPNKATDR
IVQGVDEIKVCMAASATDAADACNSSMGQRSAFVVEAARLIKESPILGHG
AGGFYYENKEVDYKVNNPHNQYLLETIQSGVIGLFLFLAWVICCYRVIWQ
QTPALRNVLLAVLTSYMACNFFNSFLLDSSEGHLFMIFVAVLAGYSVSGS
QSIAGKRLPT
>YPO3161 putative lipoprotein
MLKKILFPLLAIFILAGCATTSNTLNVTPKVVLPTQDPTLMGVTISINGA
DQRQDAALAKVNRDGQLVVLTPSRDLRFLLQEVLEKQMTARGYMIGADGA
VDLQIVVNQLYADVQEGNLRYNITTKADISITATAKNGNKQVKNYRATYN
VQGAFTATNEKITDAVNSVLSDVIADMAQDTSVSSFIKQNAR
>YPO1025 membrane-bound lytic murein transglycosylase A precursor
MTSRWGKYLLSGIMIAVLAGCQSRPTDRGQQYKDGRLEQSLELVNEPNAA
GKPVNAKDYSDQVKVINQSSPGLYNRNSDTFNAVQNWMLAGADTSKLSLF
GLNAYQMEGVDNFGNVQFTGYYTPVLQARYTPQGEFRHPLYRMPAKGKRR
LPDRAAIYAGALDNRNLIIAYTNSLVDNFMMEVQGSGYVDYGDGRPLTFF
GYAGKNGHAYRSIGKVLIDRGEVARADMSMQAIRQWAENHSEAEVRELLE
QNPSFVFFKPVMYAPVKGASAVPLIAKASVASDKSLIPPGTTLLAEVPLL
DDQGKFTGKYQMRLMVALDVGGAIKGQHFDIYQGIGHEAGQAAGFYNHYG
RVWVLKNAQSSGPLFTAYKGGTQSEPTSNDSSLLVNNQDR
>YPO1688 hypothetical protein
MKQFPFDKRYEIEDAHGSVEYYIDGDEYIRNQDGIPGYRIDGYEVYEQGI
ESKLAGFLEGKHITTPDADTLLTILDEQSPVD
>YPO1364 putative HlyD family secretion protein
MMQLSRGQRRWLAAIAVLLIGGFFIARHLMAPVPVNYQTVKVVHRDLQQN
VLATGKLDAVRKVDVGAQVSGQLEKLYVEIGDHVKRGQLLAMIDPQQAQN
QIKEVEATLQDLNAQRIQAKAELHLATVTLGRQQNLAKLQVVSRQDLDQA
VTDLAVKNAKVGTIDAQINKAKASLDTAKINLDYTQISAPMDGDVVQITT
LQGQTVIAAQQAPNILTLADMSTMLVQAQVSEADVINLKPGMKASFTVLG
DPGKRFSGVLKDILPTPEKVNDAIFYSARFEVPNPDRLLRLQMTAQVSIQ
LANVDQAVVIPLAALGDELGSNRYQVTVLKEGKEEKREVTIGIRNNVDAQ
VISGLSVGEDVIVSRGGTGDA
>YPO3129 putative potassium efflux system
MSSRARIALFDPFLFCRQTMFTLVIIVLLLFSSTFVFGISAFASGINVDV
PTRSEVQSQLDLLSKQKILSPAEKLAQQDLTQTLEYLDTIERTKQEANQL
KQQLAQAPAKLRQATEGLEALKSSSADTMTKESLANYSLRQLESRLNETL
DNLQSAQEDLSAYNSQLIALQTQPERVQSAMYSASMRLMQIRNQLNGLTP
NQESLRPTQQQELLAEQVMLNGQLDLERKNLEANTTLQDLLQKQRDYTTA
HINQLERYVQLLQEVVSGKRLILSEKTVKEAQAQTDGSDIQNDPLISREL
AINKELSERLINATKEGNTLVQQNIRVKNWLDRALQSERNLKEQITVLRG
SLLLSRILYQQQLNLPASGLITNMGPRIADLRLEQFEINQQRDKLFQGDD
YIQTLMESSKEKVDPNVEDALGQIVDIRRELLDQLNKQLGNQLTLAINLQ
INQQQLLSVNESLQHTLTQQIFWVSSNKPMDWSWLKALPGAIKTELSNFQ
VTLSLGDALAGLLKSLVFLIPMLVVAVVIRSRYHMINTYLDQLAADIGQL
KRDSQMHTPKAILLTVLKILPNVLLILGIGYWCLRSDFNLSGLLWSFFQR
LALFWLVFELTYRMLSPGGITERHFMISTDRCAHYRRQIVRLGAALLPVI
FWSVLGERSPLRLVDDVIGQIVIVIALALLALFIFPFCRDSWREKDSHAV
RLVIITAITATPIVLMGLMVAGYFYTTLQLAGRWIDSLYLLFLWNIVYLT
AIRGLGVAARRLAYRRAIARRQSMGKEGAEGSEPIEEPPLALDQINQQSL
RLTTMALFLIFATCFYWIWADLITVISYLDSISLWHYTATVAGASVTQAV
TLGNMLVALMALVVAYVLTRNLPGLLEVVVLSRLQLRQGTSYAITTILTY
LITAVGGITALSSLGVSWDKLQWLVAALSVGLGFGLQEIFANFVSGLIIL
FERPVRIGDTITIGTYSGTVSRIRIRATTITDFDRKEVIVPNKAFVTERL
INWSLSDTITRIIIKVGVAYGSDLEKVKEVLLQAAHANSRVMTDPEPQVF
FLNFGSSTLDHELRLYVRELRDRSYTVDELNRAIDKLCRENDINIAFNQL
DVYLHKPDGTEVQEISRPIEATSLPATQSMLGKPKPDLP
>YPO3220 hypothetical protein
MGPVSETSKEQFVKKNKLAICAILRDLQKNDTAVMVTHARGQFISRILDI
QPETNQFIFDFGSVENENVLALGAEQLTIIVEPTGAKIEFTCNKLKHVEY
LSLPAFSSAIPEQLYFIQRREYFRVSIPQWPAYYCSGKFPDGTQYKYTLA
DISLGGMGLYAMKGSEFPLQGCSVLRDAAVDLCGFGLFKLDLQFIRALDK
QVVNNKGEMLTVQRLSFKFLRLSPIQEKGLQRAIFELEKQQTAKARKFQE
GL
>YPO2117 hypothetical protein
MAVKFTLVPSPTFKVDVTIPRAGLDDGILTFTFRHMPVNEVINMEKVEGQ
SGLDFAEKFIEGWALPEVFSRENLEVLANNYPKAIEAIVGAFYRELLGNR
EKN
>YPO0974 putative OmpA-family membrane protein
MSRWWQRGLWLWAGLLAVILCLAFLPLSPWGRWLMLAWVVLICMLGGSRA
GRQAAGASSDPLFAGLATENGLLPENSRLPVVLVCGDGLASWFGRERSHQ
SAQGCWLRVDDISTLRQFARQLLWQRPEWAAQLAVMMVVNPQQRRDERLL
AADLQELRWQLMQLRRDSRHPVPLLLSSTVATSVARDTVWLSQQQTPPLT
LWSTVSTPGSLADWQRAESRAVQAERLKQAVLFSSQHDWLNAQVLPVLQA
PNADVDPLAPQQIIQQQVASLADPVPASLWQHWLAAHTTLTQVAGWHPPP
PAAHDALPLPDFVFSALPLGSGVSSRRRVLRHGVTLLTLAAMVALCSSAW
QNRQLLHRVAFDIRQYHSVAMTDYSPKAQAVAVLHRDAGLLDEGYRNGEP
LRLGLGLYRGERLRPPLLAAIKSYIPPPPPPPAPPAPKTVRLDSLSLFDV
GKFTLNAGSTKMLVTALIDIKAKPGWLIVVAGHTDITGDAQANHILSLKR
AEALRDWMLSTSDVSPTCFAVQGYGATRPIADNDTPDGRALNRRVEISLV
PQADACQGPDVKTASQDESDVSTQEMEK
>YPO1356 hypothetical protein
MTPQRILVLGASGYIGQHLVPLLSQQGHQVTAAGRRIEWLKEQAWPNVNC
CFVDLYQPATLNAALQDIDVLYYLVHGMGDGQDLIEQERLAASNMKNALQ
PLGTAQTSSVKQIIYLGVLQPGDNSSSHLIARKLTGDILRQSGIPVTELR
ASIIVGPGSAAFEVMRDMVYNLPILTPPRWVRSKSSPVALDNLLVYLTEL
LNHPTEENRIWDVAGPEYISYQTMFERFIAISGKRRWLIPIPLPTRFISV
YFINMITSVPTSIASALIEGLNHDLPADGRALQALIPQKLIRFEDAVKET
LRREDEVVDSADWGYDPEARARWRPGYGFYPKQAGCQRSTTASSEALWHV
VQQIGGKEGYFYGNPLWKIRARMDDMIGGGVVYGRPERETLELGDLIDGW
KVITVKPLRQLALMFGMKAPGLGRLTFTIKDLGGCRSLDVRAWWHPAGFS
GLLYWFVMMPAHLFIFRGMARRITALAEHDDRERDARAKNSAGSKQ
>YPO0284 hypothetical protein
MRPWLIFGAGRGVGAHLLALANQHADSASNPRPVTLLIRNQQQAEELRNK
GLTVVCGDACDPASVREACQLAGEDAAIISTLGNNNANYQGNRLIIDTAE
QLGLKRMLLVTSIGCGDSWPTLSPAARAAFGQAVREKSLAESWLQTSNLI
YTLIRPGGLLDQPATGNAIRLQTEAHGMVTRADVAHHISQMIEDPATYYQ
AYALIEPGLARKVKMN
>YPO1382 hypothetical protein
MNENWNWSLVDKVVYINLKERTDRNEHIKKELEKVCFPPEKIIRFEAIRA
GSGFIGCAKSHLAVLKMAQENNWRNILILEDDMVFEDDDETIIRTNNFLS
KLNNIHWDAAFLSASYYIVNAIDDNFFKVNFAYLANSYLVNNHYYEKLIN
NYTESVQRLTNGESSSEYGLDSNWLKIMKIDNWYGIYPVIGYQRTDISDI
EYKEIDRTHQFTRTFDKMKAYGSK
>YPO0186 putative sugar transferase
MQRILVIRIDFLGDMVCTTALLHALKQRWPAAEIHVLANKYNQSVLARNP
DVSAVHTYVYSKQCERNQRPGRLMALFDRLALIWRLRRLGFDLLLIPNGG
MNKNSIQFAKQLNVADRRWHTAETEFDDRNPEHVATRPIRHEALSGFALM
PELGRVDIETLKLHVYPEPQLQAKWQADLGGKDRPRVGLFISNKSAQRRW
SWDKWRQLALKLNAQAELLIFHDPAEQPSEQQLAGLTARCLSTPSTDDLM
AAMSQLDLVISADSAPVHIGSALQIPVVALFESRPEKYLRWYPLGVRHVL
VHAGPQVEDIHVDAVESAARSLLTTD
>YPO2062 putative M23/M37 peptidase-family protein
MLGSLTVMTLAVAVWRPFIYHPEHEPVAKSVVLDTSQSRILLPEASEPLD
QPTPDDAIPQDELDTKDANDTGVHEYVVSTGDTLSSILTQYGIDISDVSL
LANQNRDLRNLKIGQQISWTVNDTGDLQSLTWEVSRRETRTYNRVGNNFK
ETKELQKGEWKNSVLTGRLDGSFVGSAKKAGLTAAEIRAVTKALQWQLDF
SKLRKGDQFAVLMSREMLDGRSEQSQLVGVRMRSGGKDYYAIRAEDGKFY
DRQGSGLARGFLRFPTLKQFRVSSNFNPRRLNPVTGRIAPHKGVDFAMPV
GTPVLAVGDGEVLISKFSGAAGNYVVIRHGRQYTTHYMHLKKLLVKPGQK
VKRGDRIALSGNTGRSTGPHLHYEFWMNQQAVNPLTAKLPRSEGLSGKDR
SEYLAIVKQVIPQLQLD
>YPO0452 putative soluble lytic murein transglycosylase
MGKWRYLAIGVCLMTTSGVTFADSLDAQRQRYQQVKLAWDSNQMDTVAQL
MPTLRDYPLYPYLEYRQLTQDLSQVSTAQVKDFLNRHPTLPPAKSLPSRF
VNELARREDWRGLLTFSPTAPKPVAARCNYYYAKWATGEQSVAWEGASEI
WLNGQSLPGSCDKLFSVWQQAGHQTPLATLARMKLALKEGNASLVSYLLK
QLPADYQTMGTALAKLQSDPSSVESFARTVGPTDFTRSATTIAFTRLARQ
DVENARLMIPSLVRLQKMSDSEKLELEEAVAWRLMGNDATYEQAKWRDQV
ALRSHSTSLLERRIRMSLGSGDRQGLATWLARLPAEAQDKDEWRYWRASL
LLEQGKKAEGEAILRSLTKERGFYPMVAAQKLNIPYPIKVQVAAKPDVSL
AQRPEIARVRELMYWNMDNQARAEWSYLVASRSKAEQEALARYAFDQKWA
DLSVQATIVAKLWDHLEERFPMAWTKEFRQFTEDKGITPSYAMAIARQES
AWNPKAQSPVGATGLMQVMPRTAEHTVKRNNIAGYLNSSQLLDPVTNIEI
GTYYLEEVYQQFGRNRILSSAAYNAGPSRVNTWLGNSGGQVDAVAFIESI
PFSETRGYVKNVLAYDAFYRHFMNRPAKVLSDAEWQRRY
>YPO1705 tail-specific protease precursor
MNKFVRLAAIAGLLLAGASYATDTTYRIDQLPQLRQEPEHATVSERVTSR
FTRSHYRQFALDDQFSAKIFDRYLNMLDYSHNVLLASDVAQFADKKYSLD
KELKSGQLDTPFALFNLAQKRRFERYQYALSVLDRPMVFTGNDTIDIDRA
KAPWPSSEAELNALWDAKVKYDQLNLKLAGKTDKEIKETLTKRYQSAIKR
LTQSNSEDVFQLIMNAFAREIDPHTNYLSPRNTEQFNTEMSLSLEGIGAV
LQMDDDYTLINSMVPGGPAAKSKTIAVGDRVIGVGQAGKPMVDVIGWRLD
DVVALIKGPKGSKVRLEILPAGKGTKPRTVTLTRERIRLEDRAVKMSVKT
IGKERVGVLDIPGFYVGLTEDVKVQLQKLEKQNVSSIIIDLRSNGGGALT
EAVSLSGLFIPSGPVVQVRDNNGKVREDSDTDGVVYYKGPLVVLVDRYSA
SASEIFAAAMQDYGRALIVGEPTFGKGTVQQYRSLNRIYDQMLRPEWPAL
GSLQYTIQKFYRVDGGSTQRKGVTPDIVMPTGVDPAETGENFEDNALPWD
RINAASYTKTGDLKPWEPELLKNHAERIAANPEFQYIQKDIERYKALKDK
RNIVSLNYAQREKENRDDDMTRLTRLNERFIREGKKPLKSLDDLPKDYQE
PDPYLDETVNIALDLAHKEKAQPQIASRPVAAATAGATVK
>YPO1982 putative dehydrogenase
MTNILITGASGFIGGAFMRRFACHDGIRLCGIGRRSVEGFPTSVRYQALD
LARLATLDFTPDVVIHAAGRAGPWGTRREYYRDNVVTTEQVIKFCQSRGN
PRLIYLSTAAVYYRYCHQLALTEQSEIGPEFANDYALTKHQGEALIEAYQ
GEKTILRPCAVFGPGDQLLFPPLLDAASRHGLPLLISEVPARGELMHIDV
LCDYLLKAAIKPELRLFYNLSNAEPIEINEFLIDVLSKLGLPAPKREVRV
ATAMLIAGIIEGTYRLLRIKSEPSITRFGVGVLGYSKTLDVSAAIHDFGS
PSRSLSQGLDAFIRWYKEQK
>YPO3290 hypothetical protein
MFSLRHTKALPFYISTLTLSLFSASALADATLFTALDDPSSAKKSFDGSV
DAGYTAQSGNTTNSSLAANSTLTWFQPNTAYSLWGAARNTSANNQRSSER
YQLGGRTRYNLTDRHYIFGQASWLTDRYNGFDSRSVLTTGYGRQVMTTPL
HNLRVEFGPGVRHDEFYGGGRATKALAYGGANYTYQLTDNTVFSEGVSAL
ANEETTLNSETALNVAINKSFALRLAYIATYNTKPPTSAPKNTDTTTSIT
LVYGL
>YPO4076 putative lipoprotein
MKKRILAPVAIVSVALILSACTTNPYTGESQAGKSGYGAGIGAALGAGIG
LLSSSKHDRGKGALIGAAAGAALGGGAGYYMDVQEAKLREKMSGTGVSVT
RQGENIVLNMPNNVTFDTNSSNLKPAGANTLTGVAMVLKEYDKTAVNVTG
YTDSTGARAHNIVLSQQRADNVASALIVQGVAANRIRTYGAGPDNPVASN
STAAGKAQNRRVEITLSPL
>YPO1000 putative drug efflux protein
MFTLNWVRSTPIFYVPRTLRSRLILRSPRMGPLRAKQHRHSLLSHALFLL
ILGVGTVSAATAPLPAVTVAVVASITPDNAVQYLGRIEAIQAVDVTTRTE
GFIARRLFTEGKMVKQGELLYEIDPALHQASVAQAQAQLDSATASANHAQ
VNLTRLQRLGNNRSVSQAEVDEAQAQRDISRAAVAQAQANLQIQQLQLSF
TQIHAPISGQMGHSRFNVGSLINPASGTLVNIVQLDPIRVAIAVNERDYI
TATYQRAVAREKNIENPLLLLGTFTPRIQLANGKQYPESGVFESVDNQID
KQTGTVIIRTRFANPRHLLLPGGVVNVSLAADDAKPVTVIPIAALQQNKQ
GHFVLVVTDKAVVEVRPVTLGEQFEQQYAVTDGVKVGEKVIVAGLQHVRP
GMAVNASTVNDGTVNDRVAAPLTAN
>YPO0187 putative glycosyl transferase
MNSVDISVIVPVYNCANYLTDLLDSLRSQTGVSLEIIAVNDGSTDHSLAL
LEQVAHIDSRLVIINQQNQGLSEARNVGIAKAKGNWVAFADGDDWLAPHA
LSTWLQQVKQQKLDVLIGNGYQFSSNPERKPVTPLLGQQPWGATLNGQQW
IILSVKQKEWPHYAWLQLIRRDVISTHQLQFIRDMLHEDILWTTQLALVA
QRIGFCATPFYGYRTNPDSITNSPSMQALLRRANSYVDIINALVKIAAST
KPPVRDALLSHANQESGHLLGLLRKKLPASPQRTALAIRFITLGLRPALF
RGVTNLHELWRAIRCSFLMGSYARQKRAE
>YPO1469 hypothetical protein
MSRWWQRGLWLWAGLLAVILCLAFLPLSPWGRWLMLAWVVLICMLGGSRA
GRQAAGASSDPLFAGLATENGLLPENSRLPVVLVCGDGLASWFGRERSHQ
SAQGCWLRVDDISTLRQFARQLLWQRPEWAAQLAVMMVVNPQQRRDERLL
AADLQELRWQLMQLRRDSRHPVPLLLSSTVATSVARDTVWLSQQQTPPLT
LWSTVSTPGSLADWQRAESRAVQAERLKQAVLFSSQHDWLNAQVLPVLQA
PNADVAPLAPQQIIQQQVASLADPVPASLWQHWLAAHTTLTQVAGWHPPP
PAAHDALPLPDFVFSALPLGSGVSSRRRVLRHGVTLLTLAAMVALCSSAW
QNRQLLHRVAFDIRQYHSVAMTDYSPKAQAVAVLRRDAGLLDEGYRNGEP
LRLGLGLYRGERLRPPLLAAIKSYIPPPPPPPAPPAPKTVRLDSLSLFDV
GKFTLNAGSTKMLVTALIDIKAKPGWLIVVAGHTDITGDAQANHILSLKR
AEALRDWMLSTSDVSPTCFAVQGYGATRPIADNDTPDGRALNRRVEISLV
PQADACQVPDVKTASQDESDVSTQEMEK
>YPO2385 hypothetical protein
MGSVIMRLMLTLFVLLFTQLFLNLAHASPQAHSSVEQKKGHVSQASPDDR
KKRKADKSTKRSKIATTKGPVSKKTTEPRKTGNNKTSTNKVVRNKINSSR
TTESKTAANKKRTSSIRTAKTPYGRQRNKAQGKASTELAANNKLKLSPAH
KKRYQKAKQTAMSKLMKQVGKPYRWGGSSPNTGFDCSGLIYYAYKDVVKI
KMPRTANEMYHLRDAAPVKRTELESGDLVFFKIANRGVADHVGVYLGNGK
FIQSPRTGEEIRISMLNNDYWQEHYVGARRVVTPKTIR
>YPO0390 hypothetical protein
MSLQARRCDRPVASHINTQLPASGLSSVLSAQGHLKRLLIQHGFGQQLLE
SGVLFLKRLQTLNLGHLHTAILFTQGVKRGVGNGVLAAEFTGGYPGFSLA
ENTDDLLVGKTLLHGDVLMWFMKTLLTSGSVNQRGAGQGGWYEVLASARV
SFKGK
>YPO1051 hypothetical protein
MMSILWSLAAFIVALGILITVHEFGHFWVARRCGVRVERFSIGFGKALWR
RTDRQGTEYVIALIPLGGYVKMLDERVEAVAPELRHQSFNNKTVLQRAAI
VSAGPIANFLFAIVAYWLVFIIGVPSVRPVIGDISPQSIAAQANISSGME
LKSVDGIETPDWDSVRLALISRIGDKQMQVGVAPFGSDNVVEKTLDLRQW
QFEPDKQDPVVALGIIPRGPQIESVLAEVQPGSAAQKAGLQAGDRIVKVN
GQLLDRWQTFVLQVRDNPGQPLVLDIERESTPLSLTLIPDTKSVGENRSE
GFAGVVPKVIPLPDEYKTIRQYGPFTAVYQAGDKTWQLMRLTVSMLGKLI
TGDVKLNNLSGPISIAQGAGLSAEYGLVYYLMFLALISVNLGIINLFPLP
VLDGGHLLFLAIEKLKGGPVSERVQDFSYRIGSILLVLLMGLALFNDFSR
L
>YPO3483 multidrug efflux protein
MHSKIILACLVFTLVACDQSSSPSATPSRQEVGVVTLKTQPVTLSSDLSG
RTVAAMTSEVRPQVDGIIKKRLFTEGSEVTAGQVLYQIDPASYQAAYDTA
KAALQNVQVSVKSAKLKAQRYAALAKENGVSQQDADDAQTSYQQALANVA
EKTAALETARINLAYTQVRAPISGRIGISSVTPGALVTANQTTALATIRN
LDPIYVDLTQSSAQLLALRKQQQAGNDTVANAPVQLTLEDGSVYAHEGSL
QLTEVAVDEATGAVTLRAKFPNPEHQLLPGMFVRASVRNGVNNTAILAPQ
QGITHDAKGNATALVVNQQQQVERREVVTERTIDSYWLISRGLAAGDRLI
VEGTEKVSVGDDVKPVEVSTTLPVVAEPTTPSTGEK
>YPO3466 hypothetical protein
MAKVLLLGASGLVGGELLRLLRLDARVTSIIAPTRNPLPAMNKLINPHGE
NIGQLLKMLHEPVDLVFCALGTTRKQAGSQAAFRQVDYRLVLLSGETGRR
LGARHFLLVSALGANPDSWLFYNRTKGEAERDLQAQGWPQLTFARPSMLA
GQRATPRLLENLSAPLFALLPAKWRLINAKDVAQAMLDQAFAPPQEGVTV
LSSAQMQPTLRP
>YPO2312 putative insecticidal toxin complex
MRTSLFSKTPSVTVLDNRGLTVRDIAYHRHPDSPDVISERITHHQYDARG
FLTQSADPRLHGAGLMNFSYLTDLTGRILRTQGADNGTTVSLNDAAGRPF
ISASNISTSDDGTEDRGQAMTRTWQYEEASLPGRLVSVTEQVTGKATRIT
ERFVYAANTDAEKSLNLAGACVSHYDTAGLVQPDSIALTGVPLSVTRRLM
KSADNPDAVADWQGADASAWNDQLDGETHTSLTTADATGAVLTTTDAKGN
LQRMAYDVAGLLSGSWLTLKDGTEQVIVKSLTYSAAGQKLREEHGNGVVT
TYEYEPETQRLVGIKTERPAGHASGAKVLQDLRYEYDPVGNVLKVTNDAE
ETRFWRNQKVVPENTYTYDSLYQLVSATGREMANAGQQSCSLPSTTVPLP
ADSSAYTRYSRTYTYDEAGNLTQIRHNAPATNNSYTTKITVSDRSNRGVL
STLTENAADVDALFTAGGQQTKLQPGQHLIWTARNELLKVTPVVRDGSTD
DSESYRYDAASQRILKVSRQKTNTSMQTQRVLYLPGLELRSKKSGDTETE
GLQVITVGEAGRAQVRVLHWESGRPDEITDDQIRYSYDNLAGSCSLELGG
DGNIISAEEYYPYGGTAVWAVRRAVEADYKTVRYSGKERDATGLYYYGYR
YYQPWAGRWLSADPAGMVDGLNLFRMARNNPVAFIDRNGLNSELLYSQAF
KRTANKYNVIIGVRAPNPLGETLLKEGFPSKNFHMKAKSSPTGPTAGFIA
EDPIYSKVSPSAYKKQRASIDKAKALGSESIDLFISKSRINELIDTGNLN
SLGENRYSAKYPYGTQEFEIGNNGRVLNSEGKPVKVMTNPPEIGERKSNS
SPITADYDLFAIIQVLISQLMKDP
>YPO0833 putative phosphosugar isomerase
MTQYLGYSREELTRLHASWTAQEIEQQPACWGKTQRIVEESQAAINDFLH
QALAASNTRIIFTGAGTSAFAGRALAPLLAPYLSHRIEAIATTDLVATPE
QYFSEDIPTLLVSFARSGNSPESVAALQVASACLSRCFHLVLTCNQGGQL
YQYCQTAPGALAVLMPAETNDQSLAMTSSFSSMMMAAMAIFAGIDKYSKE
IERFCKGSADWFKEINHKIIDNTKSSQYQRVIYLGSGGLQGLAQESALKL
LELTAGKVVATFDTPLGFRHGPKSIVNPDTLVVVYISNDPYTRQYDLDLL
AEVRANNVAGKVIAIAAQSDAYVTAGDHVLVPGMAESSDLGLLFAYLMFA
QSFAFHSSVALNNTPDSPSPTGEINRVVQGVTIYPFKK
>YPO1411 putative outer membrane porin C protein
MMKRNILAVVIPALLAAGAANAAEIYNKDGNKLDLYGKVDARHSFSDNNK
QDGDKSYVRFGFKGETQITDQLTGYGQWEYNIQANNAEDTGAQDGNATRL
GFAGLKFAEFGSFDYGRNYGVIYDVNAWTDMLPVFGGDSISNSDNFMAGR
STGLATYRNNNFFGLVDGLNFALQYQGKNDRSEVKEANGDGFGIGSTYDI
GNGINFGAGFSSSNRTLDQKYGSTAEGDKAQAWNVGAKYDANNVYLAVMY
AETQNLTPYGSFSDTIANKTRDIEITAQYQFDFGLRPSLGYVQSKGKDLN
DVDANHDLLKYVSVGTYYYFNKNMSTYVDYKINLLDEDEFTIANGLNTDN
VVAVGLVYQF
>YPO0919 hypothetical protein
MEELNVVEGINNASTWLANNQDLLIQYAVNIIAALLILIVGSIIAKVLSG
MLNRVMRLRGIDVTVADFLSAMVRYSILAFTIVAVLGRLGVQTASVIAVI
GAAGLAVGLALQGSLSNFAAGVLLVAFRPFKAGEYVDLGGVAGTVVQVQI
FSTTLRTVDDKIIVVPNGKIIANNIINTSREPNRRTDMIVGVAYDADIDV
VKKVLGDIIAADSRIIHEKGVTVRLNEMAPSSLNFAVRVWTTNGDAQEVF
WDLTENFKRALDAHKIGIPYPQMDVHLHQVAKAEAEKPE
>YPO3533 hypothetical protein
MGRIAPRRRKNNRVYQPLLHSWLTIRQKVLPDAKNTDEQNLISEINAPEQ
RVDPDNVTEPALAPTQRKGVQSIKELWLKIWHLPDSFQWMEPLPFFHRRG
VIIATTVLLLALLWPASRDNTDLSFPVSAPSTSVPLQAQLQDNNDVPVPP
KVSPSETTQGNWQSYQVQTGKTLAQLFRDNNLPVNDVFAMAQVEGSDKPL
SNLKAGQEVKIMLDAQGAVTALAIETPENTEVLFSRQNDGSYRREH
>YPO1983 putative glycosyl transferase
MIYLAAIWLGILLFKLIFTLRMMKRGTQAGCGVPQATATILQPVLSGDPQ
LATVLEANVVALKQARFFWLIDDDDTVAREIAISIQSRYPDREIKASYFP
PAPEGVNPKVFKLEQAWREVASDILLVLDDDAFLSAESFGTLLNQIEEGA
LVTALPYYCADSNGYSRLLAQFVNDNSGFTYLPLLPFSPPLTINGMCYAI
SVNTLAQVGGFAAILHDLADDLALATLLRQHHIRLIQSTAPVRVQTSLSS
GKKYIQQMHRWFLFATLLLREKTVLIKLIIFLLQGLHPLLMWAMLLTVGW
EWVTAAHGITGINLGIIAACLLIRHAALRHVQQAIAPDIRSNPIFSLLSE
LMQPLHLLHALCNRTIYWRTRRYRVLSNKKFNSL
>YPO3919 HlyD family secretion protein
MLPESVCYSVANANRQPPLQINSGRYLNIGGGLVVIGFIGFLLWAGLAPL
DKGVAVTGLLVVAENRKVIQPLQGGRIQQLHVTEGDEIVSGQLLVTLDDT
AIRNQRDNLQHQYLSALAQEARLTAEQNDLDVITFPQALLEHATQPAVER
NIILQQQLLHHRRQAHLSEIARLSTQLTRHQARLDGLQAMRSNHQRQSNL
FQQQLDSVQLLAKDGHIAKNKLLEMESQSTSLQARVEQSTSDIAEAHKLI
DETEQHVLQRREQYQSENSEQLAKAQQNTQELVQRLNIAEYELSHTRIFA
PVSGSVIALAQHTVGGVVSSGQALMEIVPSGQPLFVEAQLPVELIDKVAV
GLPVDLNFSAFNQSNTPRLQGSVWRIGADRIQPPPTSPPYYPLTVAIDLD
PTELAIRPGMAVDVFIRTGERSLLSYLFKPFTDRLHLALAEE
>YPO0420 putative lipoprotein
MKIKTVVTLLITFLLAACDRTPPETVESVRPVKIFMVEDSGQNGTRYFPA
RLQAGDETQLSFKRGGQLQELLVREGEQVKKGQKIAMLNDTDLSLRVRDR
QSTFNLARDQFNRFNTLQGRSAVSRADLDIRRAEMESAQAALDIARKELS
DATIIAPFDGIIANVNVRNHQVMAAGQPVATLSALDTLDVVFSVPERLFT
TLDISNRNYKPTVLLNHMPGREFIAEYKEHTTSTTSASQTFQVTLTMKRP
ADMPLLSGISGRVRINSGNLSGTDHPTIIVPVEAVFNPDHAQLNDARVWV
IKNDNDQMHVEERKVQVGQLVENGIQVTSGLADGEQIVAAGTGELRPQQV
VRAWVRERGL
>YPO3632 lipid A biosynthesis lauroyl acyltransferase
MIKPQKFHISLLHPRYWLTWFGLGVLFLLVQLPYPLLNKLGVWLGRTSMR
FLKRRVSIARRNLELCFPDMDKQVLEQTIIGNFESLGMGLLETGMAWFWS
DTRIQRWFSVSGLENLKRAQQGKRGVLVIGVHFMSLELGGRVMGQCQPMM
AMYRPHNNKVMELVQTWGRMRSNKAMLDRRDLRGMVRALKQGEAVWFAPD
QDYGPRGSVFAPLFAVEHAATTSGTFMLARLAKPALLPLVLLRKKEGRGY
DLLIQPALEDYPIDDEIAAASYMNKVIEKEIMRAPEQYLWLHRRFKTRPI
GEPSLY
>YPO2238 hypothetical protein
MMNIMITGAAGFLGRRLIDGLLQQDYLTDQQGEPRNINKIIAYDVLPLME
VEDPRVQVVCGDIADQNGLSAVWDRQIDTIFHLAAVVSSQAEDDFDLGMR
INVDATRSLLELARQSGQCPKVIITSSVAVFGGALPKVVPDNQVWSPQSS
YGTQKALNDLLLSDYSRRGFIDGRSLRMPTIVVRPGKPNRAASSFASGII
REPLQGHDAICPVSMQTPLWLLSPKMAIDNLIHGHELDASQLRLGRVINL
PGLSVSVQQMIDALRRLAGDEVVERIQVQRDPSIERIVNSWPGDFEASYG
KVLGFRRDPDFDSIIQDFIIENLPELAAEKHFI
>YPO3524 hypothetical protein
MLRYPILCFVCLLLATPIAYAANVRLQVEGLSGDLERNVRARLSTIGTDE
VTADGRFRSRVDEAIRQGLRALGYYDPTITFELQNRPAPARSVLIAKVVP
GEPVLIAGVDIVLQGGAKTDPDYQALVRRDTPKIGSVLNHGDFDNFTSSL
TGLALRRGYFDANMIKSQLGVAAQLHEAFWDIDFDSGQRYRFGKVIFQGS
QIREDYLQNLVPFHEGEFYTSDELAELNRRLAATNWFNSVVVSPDFQDAK
ESKILPLDAVVTPRTENTVELGGGYATDVGPRLTASWRKPWMNSFGHSLT
TTTALSAPEQTLDFSYRIPLLRNPLEQYYLIQGGFRRTDLNDTNSDTTTL
NVARFWDLSSGWQRAINLRWSLDHFTQGRVTDTTMLLYPGVSINRTRQRG
GAMPVWGDSQRYSIDVSDTTWGSDVDFGIFQAQNVWIRTLGEKNRFVARG
NVGWIETNNFDRVPPSLRFFAGGDRSIRGYKFRNISPRDSDGKLTGASKL
ATGSLEYQYNFTGRWWGAVFVDSGEAVNNFSKSDLKTGAGVGVRWASPVG
PIKLDIAAPIGDNETHGVQFYIGLGPEL
>YPO2418 dolichyl-phosphate-mannose-protein mannosyltransferase-family protein
MKLLKDSGAALLALFFVLVYLLPVNSRLLWQPDETRYAEISREMLQRGDW
VVPYFMDIRYFEKPVAGYWFNNISQWIFGDSNFAVRFGSIFSTALSAVLV
YWLATLLWRNRSTSVLATLIYLSFLLVFGIGTYAVLDPMISLWLTAAMVS
FYLTLKAENWQQKVGAYALLGVACGMGFMTKGFLALAVPVIAVLPIVIQQ
KRIKDLVVFGPIAIVCAVLLSLPWALAIAQREPDFWNYFFWVEHIQRFAE
ASAQHKSPIWYYLPILCIGVLPWLGLLPGALFKGWRERATKPELFFLLSW
VVMPLLFFSVAKGKLPTYILPCMAPLSLLMAAYATDCANNIRMRALKING
VINLLFGVACALVIVVIGLGLVKDIVAYGPQENQKVWLGVLAFAGWGVTG
FITLRNNARNWRWAAACPLLFILLVGYLIPQQVVDSKQPQNFIKNNFSEL
SSSRYVLTDSVGVAAGLAWELKRSDILMFSEKGELTYGLAYPDSQDNYIS
NDDFPTWLAQARKEGDVSLVVQLAKNEALPAHLPPADKVNLMNRLALLWY
QKTP
>YPO3987 hypothetical protein
MTRTGKVLVGASGFILLSLVAVVIFVSSFDWNRLKPTINQKVSAELQRPF
AIRGNLSVDWSREGEGPGWRGWIPWPHIHAEDLVLGNPTTLISTQESRDA
QSAQGTPLSDAFPTGEMVTLKRIDASLAPLSLLSKEVRIPRLWLTQPDIH
LQRLANGNNNWTFNLTNTSTDSASWSVDIGDIIFDRGEITLKDAILQADL
LAVIDPLAKALPFAQVTGVRRGASINSVTSTHSVNTTTPVNTTTATATTN
PVTETVKSTTPDYLFGWKVDGQYQGQPLAGSGKIGGMISMNDANVPFPLQ
ADMRYGSTLVAVVGTLTDPGNLAGLDLQLVLSGTSLDNLYPLLDVVLPAT
PPYQTEGHLSARLKQAGGAVYHYENFNGKIGDSDIHGDLTYTDSQPRPKL
AGQVDSEKLRFTDLAPLIGADSNQEKALRGERNRQPGNKVLPTETFDTKS
WGVMDADVTYTAKRIERDKSLPLSDLYTHVVLKEGMLLLDPLRFGMAGGD
LAATLRLDSHQIPMNGKVDLHVRRIQLKALLPQVQAMRSSLGRLSGDASF
IAAGNSVAGLLATSNGNVRLLLSQGQISRSLMELLGLNVGNYLVAKLFGD
DTVKINCAVADITLRNGVATPNVFVFDTENAIINITGNANFATERLNLSI
DPESKGLRILTLRSPLYVKGTFKRPDVGVKTGALIARGAVAAALGVALTP
AAALLALISPVKVKVKRISAPRYCEKYSKRNNVLLHREVR
>YPO3054 putative carboxypeptidase
MTDNTLTPQMLTGLSTDHLVVLSGAHRLQPQAAEAFQAMQQAAKVAGFDL
QPASTFRDFGRQLAIWNGKFRGERPVLDQDSQPIDIFSLDTAARCEAILR
WSALPGTSRHHWGSDLDIYDPSRLPTGEKLQLEPWEYDAGGYFYPLTQWL
SAHMAEFGFYRPFATDNGGVAVEPWHLSYRPLAEQAEHLLTPKILLAAWQ
SQDVAGSEWLASHLPMIFSRFIYLK
>YPO1355 hypothetical protein
MKVLVTGATSGLGRNAVEYLRRQEISVIATGRNQAMGALLTKLGAKFIHA
DLTDLVSSQAKAMLADVDTLWHCSSFTSPWGTEQAFALANVRATRRLGEW
AAAYGVENFIHISSPAIYFDYHHHRNIQEDFRPVRFANEFARSKAAGEEV
IKLLALSNPQTHFTILRPQGLFGPHDKVMLPRLLHMIKHYGTLLLPRGGD
ALVDMTYLENAVHAMWLATQSQKTLSGRAYNITNQQPRPLRTIVQQLLDA
LDMKCRIRSVPYPMMDIMARAMEKMSNKAEKEPVLTHYAVAKLNFDLTLD
TLRAEQELGYRPIISLDEGILRTARWLKEHGKFRG
>YPO4112 hypothetical protein
MSFYIRKNMVLSLLWGLWVAALVAYAIYDLFFYLFIVPALFLIFTVSNVM
FKKKVNSNNDGSSSVNIPSQTSMPLSNASQENAKNNTIIAAGTQLKGNIN
LDGDIQIYGVVMGDIIVNEGSIRLMRSGQIEGNLTAPHITVDGRVEGVCI
SDDLEILEHGRLKGIVKGSNFSIKKGGIFVGQSEITEEPVSQVKSKAKPV
IAISQDKAKAEDVAAGQHSSNVS
>YPO1526 hypothetical protein
MRRLLTMLVILLIVLVAGMSALVLLVNPNDFRAYMVKQVEKKSGYHLQLE
GDLRWHVWPQLSIIAGRMALTAPGALEPVVSAENMRLDVKLWPLLSHQLD
VKQVMLKGAVIRLTPDSEAQQQIDAPVAPIAPAGSTPVSDNRGWTLDINR
LQIADSLLIWQRSDNDQINVRDINLELKQGGQRQVQVTLASRVNRNQRDL
TFSMVIDADMHQYPRQFSANISQFTYKLEGADIPAGGISGGGALEASYQS
DIQQLLLNQLNFTANNNQLAGSVKATFGDVPDYVVNLTSDNLNLDAIFGW
QPKSSTASTDEAKQPVTTAPVIAIQIDDDVGQNLQALRDFTAQTTVVANN
VVYRNININQLNLQATNQQGDLQVTRLTGNALEGDFSLAGALDVTGKKVL
ATVNPLINHMELGPVLQAAGLPQVMTGKFSMQAQLSGDGVNLAAFKHRWR
GEAQVSMNNARLQGLNIQQLIQQAVTRSTNDVKGQERYERYTEVKQLQAS
LALNRGAVKVSGLNASSSLISVKGSGGLNLPTQQCDMNLAVRVMQGWNGQ
SSLVKTLQNTDIPLRIYGPWTQLNYQLNVDQLLRSELQQRAKKALGEWAE
RNQQNRRVDDLKKSLDKL
>YPO2155 hypothetical protein
MKKDRKEMNQIKTLAALTVALAVCMPTANAGNWSLGASALVSPDPYRGKN
DRVYPVPVVSYESDNFYFRTLAAGYYLWNDSSNRLSIDAFYSPLHFKPGD
SDDQQMKQLNRRRSTMMAGMSYSHIEDWGTLRAMFAGDILDNSDGFVGDL
AYLYRFSIDSWTLTPGVGVSWSSKDQNSYYYGVSRGESARSGLAEYNPSD
SWSPYLELSANYNINPNWNAFFTGRYIRLANEVKNSPMVDQSYTGVLWTG
VTYTFR
>YPO1567 putative racemase
MNPDPDYSAAYVILDTDNPALSGHGLTFTIGRGNEICCVAIHALEHLIVG
RDLASMTANMGKFWREFTSDSQLRWIGPEKGAIHLATGAVINAVWDLWSK
AEGKPLWRLVADMSPEELVRCIDFRYITDCITPEEALTLLQQRAHNKALR
LEKLQDEGYPCYTTSAGWLGYPDDKLRRLCQDAVDAGFDYLKLKVGRDLE
DDIRRVRITREVLGPDRKLMIDANQIWETNEAIPWVNQLAFANPWFIEEP
TNPDDIEGHRRIRQGVAPVKVATGEMCQNRIMFKQFIMREAIDVVQIDAC
RLGGVNEVLAVMLMAAKYDLPVCPHAGGVGLCEYVQHLAMIDYLCIAGTD
KGRVIEYVDHLHEHFVHPCVIKNAAYMPPEQPGFSIEMHQSSIEKYRFRV
>YPO0370 putative N-acetylmuramoyl-L-alanine amidase-family protein
MIIGLLTLSLFALPPAFAMKLTDIKVTNGASESKVTLSFDGKPIYAFFSL
NSPERVVLDVRQSGNISGLPLEFSGQNLLKRIRSSTPKDEQSTRLVLELT
QKVKTRAVTQQSGNNYTVVLTMTAVASAPVRQAQASLNQTNTPSPNAGRV
VPQVTSKDSVAKNPFNNKPVVVVSSENVTTNTARPIKTVSAANSSRVVVA
IDAGHGGQDPGAIGQNGLKEKNVTISIARRLEALLNRDPMFKPVLTRNGD
YFISVMGRSDVARKQGANVLISIHADAAPNRSATGASVWVLSNRRANSEM
GNWLEQHEKQSELLGGAGDVLANTASDPYLSQAVLDLQFGHSQRVGYDVA
TKVLRELQTVGDIHKRKPEHASLGVLRSPDIPSLLVETGFISNSTEERLL
GSSAYQEKIAQAIYKGLRSYFLANPLQSDPKVESRPLIETAAVDSSTQRS
GISQPEPIVNNISSNAQSGRSSATLPAGKSKIHNVQRGETLSGIASQYGV
SMAVLRQNNTLKNDVVWVGQRLKVPASGSTVTAVKPKTAAVAKSKPIKHQ
VKRGDTLSAIAARYGVSMSEIERVNKIKSGNVQLGQTLTIPQS
>YPO3609 hypothetical protein
MAADLLPRQGDIWRKFSFDTAGELSMATDFIRGEQQYRYDAEGRLTDSRE
RHQLSVAEDFAYDNADNLLNLRKLPFDTVDPLYDTPVANNRLTQWQHYRF
EYDAWGNMTTRHAGGRMQHFAYDDDNRLLRAWGTGPLGEHDSHYRYDALG
RRIHKSVTIKRGAEKTTRQTDFIWQGLRLLQEQHTDGNATYIYDPNESYT
PLARVDQRHGETESQVYYFHTDINGTPLDVTDGEGKHRWSGKYHAWGKVT
RQNVSDPRQSTVSRFAQPLRYPGQYSDDETGLHYNTFRYYDPEIGRFSTQ
DPIGLAGGINLYQYGPNPLTWIDPWGWAFGGVDFTGSPDLFPVKGSQLNI
VEITMQGARGRDFTEAFKLAGISKADATGYTWHHLNDFDPVSGKTTMQLV
TTSAHEATFPHAGSVSQFEKHFNLPSQSYGSADAVAISHSKGWLKGRIPK
ALRSGC
>YPO1052 putative surface antigen
MAMKKLLIASLLFGSATVYGADGFVVNDIHFEGLQRVAVGAALLNMPVRV
GDTVSDDDIGKTIRALFATGNFEDVRVLRDGNTLIVQVKERPTIASITFS
GNKAVKEDMLKQNLEASGVRVGEALDRTTISNIEKGLEDFYYSVGKYSAS
VKAVVTPLPRNRVDLKLVFTEGVSAKIQQINIVGNHSFTTDELISRFQLR
DEVPWWNVVGDRKYQKQKLAGDLETLRSFYLDRGYARFNIDSTQVSLTPD
KKGIYVTINITEGPQFKLNSVIVSGNLAGHQSEAEKLTKIEPGELFNGSK
VTRMEDDIKKMLGRYGYAYPRVVTQPEINDDDKTVKLHINVDAGNRFYVR
HIRFEGNDTSKDSVLRREMRQMEGAWLGNDQVEAGKERLNRLGYFETVDV
ETQRVPGAADLVDVTYKVKERNTGSLNFGIGYGTESGVSFQVGVQQDNWL
GTGNTVGINGTKNDYQTYAEFTLMDPYFTVDGVSLGGRIFYNDFKADNAD
LSGYTNSSYGADGTLGFPINENNSLRVGVGYVHNDLSDMLPQVAMWRYLE
SVGERPGYDGREGFTTDDFTLNLGWTYNNLDRGFFPTSGVKSSVNTKITV
PGSDNEFYKVTFDTSAYQPLNEDRSWVLLGRGRLGYGDGIGSKEMPFYEN
FYAGGSSTVRGFRSNNIGPKAAYYANGGATVTNSTDAVGGNAMAVASIEL
ITPTPFISEKYSNSVRTSIFIDSGTVWDTNWENTAKTRAAGIPDYGKASN
IRVSAGVALQWMSPLGPLVFSYAKPVKDYEGDKSEQFQFNIGKTW
>YPO0099 hypothetical protein
MGKALLTSGYSTTFIAALCAIFLVLLITLIIYGTYTRRINVNGEVISQPH
PINIFSPQQGFITKKWVEVGDIVRKGQHLYQIDVSRTTFSGNVSLNSLEA
INNQLSQIDSIINNTQKNKELTLLNLRQQLAQYQKAHKKSQELVDNAGKG
MDDMRRTMASYGTYQRQGLITKDQLTNQRSLFYQQQNAFQSLNTQLIQES
LQIAKLESEISTRASDFDNDISQYLFQKGDLKRQLAEVDASGMLLINSPS
DGKIENMSVTQGQMVNVNDSLVQLTPSDNPYYCLVLWVPNNSVPYINTGD
KVNIRYDAFPFEKFGQFPGRIISISNVPVSQQEIASYNIAPRLPNGGLIE
PYYKVIVALDDIHFRYQSKPLMLSNGLKANVTLFLEKRPLYQWMLSPFYD
IKKSVTGPVNE
>YPO2922 hypothetical protein
MTRIKLSYFTIGLVALLLALALWPNIPWRNGQEGQLDQIKARGELRVSTI
SSPLIYSTEKDTPSGFDYELAKRFADYLGVKLVIIPHHNIDDLFDALDND
DTDLLAAGLIYNRERLNRARTGPAYYSVSQQLVYRLGSPRPKSFSDLKGQ
VVVASGSAHMTTLKRLKQTKYPELNWSSSVDKSGKELLEQVAEGKLDYTL
GDSATIALLQRIHPQLAVAFDVTDEEPVTWYFKQSDDDSLYAAMLDFYSE
MVEDGSLARLEEKYLGHVGSFDYVDTKTFLSAIDNVLPSYQHLFEKHAGD
IDWKLLAVIAYQESHWNPQATSPTGVRGLMMLTRATADGLGVKDRVDPEE
SIRGGAIYLQRLMKKLPETIPEDERIWFALAAYNLGYGHMLDARRLTKNQ
NGNPDSWVDVKMRLPMLSQKRYYPSTTYGYARGHEAYNYVENIRRYQVSL
VGYLQEKEKKAAQHAAIEAELGKSNPVVGPGWSIGD
>YPO1023 N-acetylmuramoyl-L-alanine amidase AmiC precursor
MADSNHNSGRRRLLQGAAAAWMLSISRVGFAASSHIVAVRVWPSSTYTRV
TLESNTPLKYRQFALTHPDRIVVDIEGVQLNSVLKEISRQVQSADPYLKQ
ARVGQFDKNTVRLVLELKQSISPQLFTLKPFAEFRNRLVVDLYPAEGGTS
AEDDPLLALLEDYNKGNVDRTLPPETPKAGKAGRDRPIIIMLDPGHGGED
PGAIGKNKTKEKDIVLQIARRLRALIQKEANMRVFMTRNEDVFIPLKVRV
AKARKLRADLFISIHADAFTNRAASGSSVFALSTKGATSTAARFLAQTQN
EADQIGGVSKSGDPYLDHTIIDLLQTATINDSLKFGKEVLSRMSKINKLH
KNRVDQAGFAVLKAPDIPSILVETAFISNLEEERKLRTSRFQQQIAESIF
AGIKAYFANGGAMARL
>YPO0416 putative lipopolysaccharide core biosynthesis protein
MIKLRHFGDVLLTTPLLSTLKANYPQAKIDVLLYGGTQDMLRENKAINHT
FIVDRGLKHAGLKAQISGEKALFSALKKQHYDLILNLSDQWRAAAYCRLL
KPTFSIGFHYPKRDNWLWRYCHSTLVEIPNAAERHTVLNNLDILSPLQLT
DIRTDVTMSYGPHDIERAKQLCQQHNIEHYILIQPSARWKFKTWASESFS
ELINHLTQQGETVLLTGSKDQAELDYIAEIIAGCTQPEKVINLSGQLALP
ELAVLIDNAKLFIGVDSVAMHMAAALQTPAVVLFGPSNLNQWHPWQAPHT
LLWAGNYRTLPHPNEIDTDTTDRYLNAIPVSDVIDAVDSWRVAKGN
>YPO3024 probable N-acetylneuraminate lyase
MKKLTGLIAAPHTPFDEQGEVNYPVIDQIAEHLINDGVKGVYVCGTTGEG
IHCSVDERKKIAERWVNAAQGKLSITLHTGALSIKDAVDLSRHAETLDIF
ATSAIGPCFFKPGNLDDLIAYCQAIAAAAPSKGFYYYHSGMSGVNLDMEQ
FLIKAESKIPNLSGIKFNNADLYEFQRCLRVSGGKFDIPFGVDEHLPGGL
AVGAIGAVGSTYNYAAPLFHKIIADFNAGDQVAVQRGMDHVIALIRVLVE
FGGVAAGKAAMQLHGIDAGNPRLPLRALTKEQKQTVVNRMRDAITLQ
>YPO0863 putative lipoprotein
MRSIGWRFFTLGWLILLAGCATDVSLSGKNKSTEANRIQFQRMGSAPESG
AADVTSLDLQPGDILLSSSTGINSLGIRIFSLAPVSHAAIYLGEEQVAEA
TSTGVNIVSLNEAIDHNTAVIAFRYPGLTPEHAAKLREFALDKEGSDYNF
GGIVLIAPYMITKRICELPLFNATVRNHCLSLLATVQLGDGGSLTEDQRF
FCSQFVLEAYNYAGHPISDSNPVWITPADLLHMREGDSSSFRSNQPLSYI
GHLKQRSSLFTGNKGLAMNNADTLLEDKSPRMLSQ
>YPO2494 putative BCCT-family transporter
MLNNPRKDIPLIVTSLLCIILIALAFSLFPQQSSQMAETIFSGVTRLLGS
TIQILVLLGLILVLYIAVSKYGNIRLGEGKPEYRTIPWLFMFICAGLGSS
TLYWGVMEWAYYYQTPGLNIAPKTPKALEYSVSYSFFHWGISAWATYALA
SLIMAYHFHVRKNKGLSLSGIISAITGVNPQGFWGRLVDLIFLIATIGAL
TISLVITAATFTRGLTALIGVPNNFAVQAGVMLVAAVIFSFSSYIGIDHG
MQRLSKMVGWGAFGFAVLVLLVGPTEFIINNTINSIGLTTQNFLQMSLFT
DPMGDGRFTRSWTVFYWLWWISYTPGVAMFVTRVSRGRKLKEVIWALLLG
SSLGCWFFFGVLESYAIQQFISGALDVPLILNTQGGETAVQMLLSALPMG
KLFLAAYLFIMIIFLASHMDAVAYCMAATSTRNLREGEDPNRMLRLFWCV
VITLIPLSILFAGASLDTMKTTVVLTALPFLLILLIEVYGFVRWIKQDYA
HVPAHLIEQSTPQVMLPAESLPPATASMLVVETLVVETAAPPASKHNQ
>YPO3132 acrA, multidrug efflux protein
MSKNRGVMPLAAILVLSGSLVLIGCNDKDAAQAGAQQAPEVGVVTLKAEP
LNITTDLPGRTSAFRVAEVRPQVSGIILKRNYIEGSDVTAGTSLYQIDPA
TYQAAYDSAKGDLAKAQASAQIAHLTVNRYKPLLGTNYISKQEYDQALSD
AQQADATVLAAKAALESARINLAYTQVRSPISGRTGKSAVTEGALVTSGQ
ASAMTTVQQLDPMYVDVTQSSDEFLRLKKELADGILKQENGKAKVRLLLE
NGVEYTETGTLEFSGVTVDETTGSITLRAIFPNPNEALLPGMFVRARLDE
GIRPDALLVPQQGVTRNPRGEATAMVVGAGNKVEMRTLIANQAIGNKWLV
TEGLKAGDRLIISGLQKIKPGVEVKVQEVTDTAPETAPADTAKKS
>YPO2905 ail, attachment invasion locus protein
MVFMNKTLLVSSLIACLSIASVNVYAEGESSISIGYAQSRVKEDGYKLDK
NPRGFNLKYRYEFNNDWGVIGSFAQTRRGFEESVDGFKLIDGDFKYYSVT
AGPVFRINEYVSLYGLLGAGHGKAKFSSIFGQSESRSKTSLAYGAGLQFN
PHPNFVIDASYEYSKLDDVKVGTWMLGAGYRF
>YPO0321 alr, alanine racemase
MKAATAVIDRHALRHNLQQIRRLAPQSRLVAVVKANAYGHGLLAAAHTLQ
DADCYGVARISEALMLRAGGIVKPILLLEGFFDAEDLPVLVANHIETAVH
SLEQLVALEAATLSAPINVWMKLDTGMHRLGVRPDQAEAFYQRLSACRNV
IQPVNIMSHFSRADEPEVAATQQQLACFDAFAAGKPGKQSIAASGGILRW
PQAHRDWVRPGIVLYGVSPFDAPYGRDFGLLPAMTLKSSLIAVREHKAGE
SVGYGGTWVSERDTRLGVIAIGYGDGYPRSAPSGTPVWLNGREVSIVGRV
SMDMISIDLGPESTDKVGDEALMWGAELPVERVAACTGISAYELITNLTS
RVAMEYLGE
>YPO1687 alr, alanine racemase
MHVRFRHLFLLPLITLVACSQPVSKNHLSLTSLSANAQQPVVNNAWLEIS
QGALDFNTKKMLTLLDNKSTLCAILKGDAYGHDLTLVTPVMLKNNVQCIG
VASNQELKTVRDLGFTGQLIRVRSATLKEMQQAMAYDVEELIGDKTVAEQ
LNNIAKLNGKVLRIHLALNSAGMSRNGLEVSKARGLNDAKTIAGLKNLTI
VGIMSHYPVEDASEIKADLARFQQQAKDVIAVTGLKREKIKLHVANTFAT
LAVPDSWLDMVRVGGVFYGDTIASTEYKRVMTFKSNIASLNNYPKGGTVG
YDRTYTLKRDSLLANIPVGYADGYRRVFSNAGHVIIQGQRLPVLGKTSMN
TVIVDVTDLKKVSLGDEVVLFGKQGNAEIQAEEIEDLSGALFTEMSILWG
ATNKRILVD
>YPO1168 betT, high-affinity choline transport protein
MVTSDIDTKPQKDTLNPVVFFTSAGLILAFCLMTIFYTDLSNRWIGITLN
WVSATFGWYYLLAATLYIVFVIYIATSRYGSIKLGPEQSKPEFSLVSWAA
MLFAAGIGIDLMFFSVAEPVTQYMMPPEGQGQTLEAARQAMVWTLFHYGL
TGWSMYALMGIALGYFSYRYNLPLTIRSALYPIFGKRIDGPIGHSVDIAA
VIGTIFGIATTLGIGVVQLNYGLNVLFHIPESLAVQAGLILLSVVMAAVS
VTSGVNKGIRILSEVNVLLALGLILFLLNALVLNVGDYINRFLGMTLNSF
AFDRPTQWMNSWTLFFWAWWVAWSPFVGLFLARISRGRTIRQFVVGTLII
PFVFTLLWLSIFGNSALYQILHGNIAFANEVMEFPERGFYSLLAQYPGFT
LSASVATITGLLFYVTSADSGSLVLGNFTSRLADINNDSPNWLRTFWSIT
IGLLTLGMLMTDGVAALQNATVIMGLPFSFVIFFVMVGLYKSLKIEDYRK
ASSQQTPTPTLISGNEVLNWKQRLSRVMNYPGTTYTAKILDTICRPAMEE
VAQELAVRGVKVEFNELPPKEDEQLNRLNHLELLVHLGDEQNFVYQIWPQ
RYSVPAFTYRARSGKSHYYRLETYLLEGTQGNDLMDYSKEQIINNILDQY
ERHMNFLHIQSEAPGNIMTFPDQ
>YPO2390 cfa, cyclopropane-fatty-acyl-phospholipid synthase
MSSSCIEDQSVQESPWFRIVQDMLNQADIEINGSRPFDIRVNNPDFFKRV
LQGGSLALGESYMDGWWECDRLDIFFQRVLQAGLEHKLPRHFKDTLRIAA
ARVINLQSKRRAWIVGKEHYDLGNDLFTQILDPNMQYSCAYWKEATSLEQ
AQEHKLQMICEKLQLAPGMKLLDIGCGWGGLAAYAARHFGVSVSGVTISV
EQQKLAQQRCEGLDVSILLQDYRDLNEQFDRIVSVGMFEHVGPKNYSTYF
KVVNRNLKPDGLFLLHTIGANRTNMNVDPWINKYIFPNGCLPSVQHIAQA
SEPYFVMEDWHNFGADYDRTLMAWYERFQAAWPNLSANYSQRFERMFSYY
LNACAGAFRARDIQLWQVLFSPNGVNGGIRVPR
>YPO2616 cutE, apolipoprotein N-acyltransferase
MSIALFLQRQWVRALLALFFGACGTLAYSPFDHWPAAIVSLFGLLSLTLN
RTTKQATFIGFCWGMGLFGSGINWVYVSISEFGGMPTAINIVLVILLAAY
LSLYTMLFAGLLARLCPKATWWRLAIAAPVLWQLTEFLRGWVLTGFPWLQ
FGYSQINGPLRGIAPLLGVDGITFILMAISGLLVYACYQRRIVAAIIALA
LLLLPWPLRQIQWFTPEPERAVNIAMVQGNIAQSMKWDPKALITTLQIYL
DETRPFMGKAPIIIWPESAIPDIETDQNTFLTMIDGLMRANHSSLITGIV
DAKRQPEGQGYQFFNSIIVLGDKDTYQYPTRNRYSKHHLVPFGEYVPLES
LLRPLAPLFNLPMSSFNRGDYVQPPLTIAGFNLTAAICYEIVLGQQVRDN
FRPETDFLLTISNDAWFGHSIGPWQHFQMARMRALELGRPLLRSTNNGIT
AAIGPSGEILAQIPQFTQQVLEVKVTPTTGITPYARFGSWPMWIITLVLG
AFTLYCAIRGRSDKH
>YPO1067 cutF, putative copper homeostasis lipoprotein
MTSFHIYRTQYGRITVSKLTITLLLAVGALSLLGCNNRSQPAEQVLQPMQ
QSYQGVLPCADCSGLDTSLFLDSDGTFILKEVYLGTKDGDQTFAEYGKWA
RTADKLVLTNGQGEKRYFHPVDKSLVMLDQQGLPIKSTLNYQLEPSDQPL
SKTPMPLSGMYKYFADAAIFTDCVTGKAFPVENNIELETGYLNARRNPGE
PVFLTLNGYFDSRPSMEEGRTNKTLIPEGDIQFNANKSCEKK
>YPO2601 dacA, putative penicillin-binding protein 5
MKYVITSRIIKSLALGTVIVMSAANADDVNLKTMIPGVPQIDAEAYILID
YNSGKVLAEMNADTRRNPASLTKMMTSYVIGQAIKSGKIGAEDMVTVGKD
AWATGNPEFKGSSLMFLKPGDRVPVSKLTRGINLQSGNDACVAMADYVAG
SQDSFVNLMNNYVKALGLQNTHFKTVHGLDAEGQFSSARDMALIGQALIR
DVPDEYAIYKEKEFTFNNIRQTNRNGLLWDTSLNVDGIKTGHTEAAGYNL
VASATDGQMRLISVVLGGHTFKGRETESKKLLTWGFRFFETVAPLKVGKE
FASEPVWFGDSDRVQLGVDKDAYLTIPRGRMKDLKASYVLNTPEIHAPLA
KNQVVGTINFQLDGKTIDQRPLVVMNEVKEGGFFSRMVDYIKLMFHRWFG
>YPO3506 dacB, penicillin-binding protein 4 precursor
MHFSRIVSGLACSIILNISVSNANAAQVENYTQYLPDGANLALMVQKIGA
STPAIDYHAQQMALPASTQKVLTALAALLQLGPDFRFNTTLESHGTITDG
VLRGNLIARFGGDPTLTRQQLRNMVATLRKAGVKQIAGDVVIDTSVFASH
DKAPGWPWNDMTQCFSAPPAAAIVDRNCFSVSLYSAPNPGDTAFIRVASY
YPVQMFSEVRTLAKGSPDAQYCELDVVPGELNRFTLTGCLTQRSEPLPLA
FAVQNGASYAGAILKDELKKADIQIDGNLRRQTIPSPAGNVLAQTQSAPL
HDLLKIMLKKSDNMIADTVFRTIGHQRFGVPGTWRSGADAVRQILRQKAG
VDLGNSIVVDGSGLSRHNLISPATMMQVLQYIAQNDQELNFISMLPLAGY
DGTLRYRGGLHEAGVNGKVSAKTGALQGVYNLAGFITTASGQRMAFVQFL
SGYAVPPEDQKNRRAPLVRFESRLYKDIYQNN
>YPO1320 dacC, D-alanyl-D-alanine carboxypeptidase
MERRYFSLIGQWRSLGIPLISDYLQGYSGDLMMKYILPFKIKNFTFSAGL
LLLALPAAYAVDDPAAPQIDAKAYVLMDFNSGKVLAEGNPDLRLDPASLT
KIMSSYVIGQSIKAGKIQPDDLVTVGKDAWATGNPALRGSSLMFLKPGDR
VKVSDLNKGIVIQSGNDASIALADYVAGSQDSFVGLMNNYAKALGLSNTH
FMTVHGLDSPGQYSTARDMALLGQALIRDVPEEYALHKEKEFTFNKIRQT
NRNRLLWNSSLNVDGMKTGYTNGAGYNLVASATDGPMRLISVVLGAPSDK
VRFSESEKLLTWGFRFYETVVPIKSTKPFVTEKVWLGDNSQVELGVAEDA
AITIPKGQMKNLKASYTLNQTELRAPLAKHQVVGTIDFQLNGKTIEQRPL
VVLNEVKEGGIFSRFWDYVMMKLNQWFGGIFG
>YPO3062 dapA, dihydrodipicolinate synthase
MFTGSIVALITPMDDNGDVDRASLKSLIDYHVASGTAAIVSVGTTGESAT
LNHDEHVDVVMQTLELADGRIPVIAGTGANSTSEAISLTQRFNDTGVVGC
LTVTPYYNRPMQEGLYQHFKAIAESTDLPQILYNVPSRTGCDMLPPTIAR
LAKIKNIVAVKEATGNLSRVSQIQVLVDDEDFILLSGDDASGLDFMQLGG
KGVISVTANIAAREMVELCALAAQGNFAEGRRLNQRLMPLHQHLFVEANP
IPVKWAAKRLGLMANDTMRLPMTPLTDPAKRIVEDALKSAGLL
>YPO3061 dapX, lipoprotein
MAISLQKSTVVKVVGVSLVMLLAACSTDQRYKRQVSGDESYLTAPGLKPL
NAPSGMILPVQNGEFDVRTVNSQGAVGKQLDIRPPVQPLTLLSGSRAENA
TDTSKLLLENSPQNRDLWAQVTRVLQDHNWPIASRQDASQTLTTDWIKWN
RADEDVQFEGRYQISVQEQGYQLALVVKSLELQQGGKTITQYSEIQRYNS
AMLNAIIEGLDKVRADSESSQASRKVGTLDVQSGSDDTGLPLLIVRAPYA
VVWERLPAALEKVGMKVTDRSRPQGTVSVTSKSLSSSSWDALGAKDPELP
EGDYKLQVGDLDNRSSLQFIGPKGHTLTQAQNDALVAVFQAAFSQTSATA
IK
>YPO3115 ddhA, glucose-1-phosphate cytidylyltransferase
MEIQVKAVILAGGLGTRLSEETVVKPKPMVEIGGKPILWHIMKLYSSYGI
NDFVICCGYKGYVIKEYFANYFMHMSDITFCMRDNEMIVHQKRVEPWNVT
LVDTGEDSMTGGRLRRVKDYVKDDEAFCFTYGDGVSDVNIAELIEFHKSH
GKQATLTATYPPGRFGALDIKDKQVRSFKEKPKGDGALINGGYFVLSPKV
IDLIDGDKSTWEQEPLMTLAAQGELMAFEHAGFWQPMDTLRDKIYLHELW
EEGRAPWKVWE
>YPO3113 ddhC, putative CDP-4-keto-6-deoxy-D-glucose-3-dehydratase
MSQEELRQQIAELVAQYAETAMAPKPFEAGKSVVPPSGKVIGTKELQLMV
EASLDGWLTTGRFNDAFEKKLGEYLGVPYVLTTTSGSSANLLALTALTSP
KLGVRALKPGDEVITVAAGFPTTVNPTIQNGLIPVFVDVDIPTYNVNASL
IEAAVSDKTKAIMIAHTLGNLFDLAEVRRVADKYNLWLIEDCCDALGSTY
DGKMAGTFGDIGTVSFYPAHHITMGEGGAVFTQSAELKSIIESFRDWGRD
CYCAPGCDNTCKKRFGQQLGSLPFGYDHKYTYSHLGYNLKITDMQAACGL
AQLERIEEFVEKRKANFKYLKDALQSCADFIELPEATENSDPSWFGFPIT
LKEDSGVSRIDLVKFLDEAKVGTRLLFAGNLTRQPYFHDVKYRVVGELTN
TDRIMNQTFWIGIYPGLTHDHLDYVVSKFEEFFGLNF
>YPO0557 ddl, D-alanylalanine synthetase
MAEKVAVLLGGTSAEREVSLLSGQAVLAGLKEAGIDAYGVDTKDFPVTQL
KEQGFDKVFIALHGRGGEDGTLQGVLEFLQLPYTGSGVMASALTMDKLRT
KLVWQALGLPISPYVALNRQQFETLSPEELVACVAKLGLPLIVKPSHEGS
SVGMSKVDHASELQKALVEAFQHDSDVLIEKWLSGPEFTVAILGDEVLPS
IRIQPPGVFYDYDAKYLSDKTQYFCPSGLSDESEQQLAALALQAYHALDC
SGWGRVDVMQDRDGHFYLLEVNTSPGMTSHSLVPMAARQYGLSFSQLVAR
ILMLAD
>YPO0313 dgkA, diacylglycerol kinase
MANQSTGLTRIYKAAGYTVKGLTAAWNNEAAFRQESVAAVIAIILAFWLD
VGAIARILLICSVVLVLIVEVINSAIEAVVDRIGSEFHALSGRAKDMGSA
AVFLTILMALFVWITVLWQHVAR
>YPO0731 flgJ, putative flagellar protein
MIEAINKSSPVIPGSFVGDLQPQDLEQAAVQFEAVFMRTLLQQMRKAAEV
LAADDDPFNSKQQRMMRDFYDDKLASTLASQRSSGIANLLIQQLGSK
>YPO1807 flgJ, flagellar biosynthesis protein
MSDLLAMSGAAYDAQSLEALKRDAARDPEGNLKQVAQQVEGMFVQMMLKS
MRAALPQDGVMNSEQTKLYTSLYDQQIAQQMSAKGLGLADMMVEQLSGST
SASETAGTVPMMLDNEVLQSMPAQALAQVMRRAIPTPPSSSMAAISPGNG
NFVARMSIPAQIASQQSGIPHQLIMAQAALESGWGQREIPTADGKSSYNV
FGIKAGSSWNGPVSEITTTEYEQGVAKKTKARFRVYGSYVEAVSDYVKLL
TQNPRYAHVAAAQSPEQGAHALQKAGYATDPQYAQKLVSVIQQMRSTGEQ
AVKAYGGSDLSQLF
>YPO0549 ftsI, penicillin-binding protein 3
MKTARPGKLKRQEEQASFISWRFALLCGCILLALVGLIMRTAYLQVINPD
KLVREGDMRSLRVQEVPTARGMISDRSGRPLAVSVPVNAVWADPKELIEQ
GGISLDTRWKALSDALEIPLDQLATRINANPKGRFVYLARQVNPAIGDYI
RKLKLPGIHLRQESRRYYPAGQVMAHIIGVTNIDGQGIEGVEKSFDRWLT
GQPGERTVRKDHYGRVIEDISSVDSQAAHNLVLSVDERLQALVYRELNNA
VAFNKAESGTAVLVDVNTGEVLAMANSPSYNPNNLTGTPKDAMRNRAITD
IFEPGSTVKPMVVMTALQHGVVKENSVLNTLPYFVNGHQIKDVARYAELS
VTGILQKSSNVGVSKLALAMPSSALVDTYSRFGFGKATNLGLVGESSGLY
PKKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSMGVYRPLSITRVDP
PVAGERIFPEPLVRTVVHMMESVALPGGGGTKAAIKGYRIAIKTGTAKKV
GPDGKYMDRYLAYTAGVAPASNPRFALVVVINDPQAGKYYGGAVSAPVFG
AIMGGVLRTMNIEPDALPTGDKSELVINTKEGSGGRS
>YPO0558 ftsQ, cell division protein FtsQ
MSQAALNARERAAEKNAARRSNGSQLAGVIFLLMVLGTILWGGWVVIGWM
KDANRLPLSKLVVTGERHYTTNDDIRQAILALGAPGTFMTQDVNIIQQQI
ERLPWIQQASVRKQWPDELKIHLVEYVPFARWNDLHMIDEQGRSFSVPSE
RMGKQVLPLLYGPEGSERDVLEGYRAINKVLAANKYQLKMVAMSARHSWQ
LALDNDVRLELGRSDRMGRLQRFIELYPMLQQQPDKRVSYIDLRYDTGAS
VGWAPVFIDNQGGEPPINGQQNSNP
>YPO1139 galE, UDP-glucose 4-epimerase
MYVLVTGGSGYIGSHTCVQLIEAGYKPVILDNLCNSKSSVLARIHSLTGY
TPELYAGDIRDRTLLDSIFAAHPIHAVIHFAGLKAVGESVNRPLEYYNNN
VFGTLVLLEAMRAAQVKNLIFSSSATVYGDQPQIPYVESFPTGSPSSPYG
RSKLMVEQILQDVQLADPQWNMTILRYFNPVGAHPSGLMGEDPQGIPNNL
MPFIAQVAVGRRESLAIFGNGYPTPDGTGVRDYIHVVDLADGHVAAMKTL
HGKPGVHIFNLGAGVGHSVLQVVAAFSKACGKPLAYHFAPRREGDLPAYW
ADATKAAEQLGWRVSRSLDEMAADTWHWQSKNPQGYPD
>YPO1540 galF, UTP-glucose-1-phosphate uridylyltransferase
MTKLKAVIPVAGLGMRMLPATKAIPKEMLPIVDKPLIQYVVNECVAAGIN
EIILITHSSKNAVENHFDTSYELEAMLEARVKRQLLDEVQSICPPGVTIM
HIRQGHPEGLGHAVLCAKPLVGDSPFVVLLPDVLIDDEQSDLTRDNLAQL
VQRFEETGVSQVLVHSVDPETLSNYSVVSCEKSTLLPGESSRINAMIEKP
QSSADLQSNLSAVGRYVLSAHIWPLLEQTKPGAWGRIQLTDAIDALAAVE
AVDAVALTGKSYNCGEKLGYMQAYVAYGLRHPQQGAEFKAWLKDFVA
>YPO1539 galU, UTP-glucose-1-phosphate uridylyltransferase
MKCLKAVIPVAGLGTRMLPATKAIPKEMLPVVDKPLIQYIVDECVAAGVK
EIVLVSHSSKNAIENHFDTSFELEAALESRVKRQLLKEIKNICPADVTIM
QVRQGHAKGLGHAVLCAKSMVGDNPFIVMLPDVLLDDSTADLSKENLASM
IKRFEETGHSQIMVEPVPKADVSKYGIADCGHVALAPGESTLMTAVVEKP
SIAEAPSNLAVVGRYVLSKNIWPLLEKTPRGAGDEIQLTDAIAMLMQQEP
VEAFHMTGKSHDCGDKLGYMKAFVTYGVRHHTEGEKFTAWLKQQLD
>YPO4129 gidB, glucose-inhibited division protein B
MLKKLDSLLTVAGITLPDQQKHQLIGYVELLDKWNKAYNLTSVRDPQQML
VRHILDSIVVNPHLQGSRFIDVGTGPGLPGIPLAIVRPDAHFTLLDSLGK
RVRFLRQVQHELGLNNIEPVQSRVEAFTSEPPFDGVISRAFASLQDMLSW
CHHLPAKPEGRFYALKGVRPDDELAVLPEDIVLESVIKLDVPELDGERHL
IILKSN
>YPO4118 glmS, D-fructose-6-phosphate amidotransferase
MCGIVGAVAQRDIAEILIEGLRRLEYRGYDSAGLAVVDSEGHLTRLRRVG
KVHALSDAAEKQDLHGGTGIAHTRWATHGEPSEANAHPHVSDYISVVHNG
IIENHEPLRELLISRGYRFSSETDTEVIAHLVHWEQQQGGSLLEVVKRVI
PQLRGAYGTVVMDSRDPSRLIAARSGSPLVIGCGVGENFIASDQLALLPV
TRRFIFLEEGDVVEVTRRSISIFDKQGNAIERPEIESQVQYDAGDKGIYR
HYMQKEIYEQPMAIKNTLEGRLSHGMIDLSELGPKADALLAEVQHIQIIA
CGTSYNSGMVSRYWFESLAGVPCDVEIASEFRYRKSAVRPNSLLITLSQS
GETADTLAALRLSKELGYLGSLAICNVAGSSLVRESDLALMTKAGTEIGV
ASTKAFTTQLTVLLMLVGRIGKLKGADASLEHDIVHALQALPARIEQMLS
LDKTIEALAEGFSDKHHALFLGRGDQYPIAMEGALKLKEISYIHAEAYAA
GELKHGPLALIDADMPVIVVAPNNELLEKLKSNIEEVRARGGLLYVFADQ
DAGFTDSEGMKIIQLPHVEEIIAPIFYTVPLQLLSYHVALIKGTDVDQPR
NLAKSVTVE
>YPO4119 glmU, bifunctional N-acetylglucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase
MSNSSMSVVILAAGKGTRMYSDLPKVLHPLAGKPMVQHVIDAAMKLGAQH
VHLVYGHGGELLKKTLADPSLNWVLQAEQLGTGHAMQQAAPHFADDEDIL
MLYGDVPLISVDTLQRLLAAKPEGGIGLLTVKLDNPSGYGRIVRENGDVV
GIVEHKDASDAQREINEINTGILVANGRDLKRWLSLLDNNNAQGEFYITD
IIALAHADGKKIATVHPTRLSEVEGVNNRLQLSALERVFQTEQAEKLLLA
GVMLLDPSRFDLRGELTHGRDITIDTNVIIEGHVILGDRVRIGTGCVLKN
CVIGDDSEISPYTVLEDARLDANCTVGPFARLRPGAELAEGAHVGNFVEI
KKARLGKGSKAGHLSYLGDAEIGAGVNIGAGTITCNYDGANKFKTIIGDD
VFVGSDTQLVAPVTVANGATIGAGTTVTRDVAENELVISRVKQVHIQGWK
RPVKKK
>YPO1953 hmsR, haemin storage system, HmsR protein
MIDRIIALLILCLVLSIPAGMILLFTGDVLLNFVFFYPLFMSGIWITGGG
YFWLRRERHWPWGDDVPAPELKGHPLVSILVPCFNEGLNARETIHAALAQ
TYTNIEVIAINDGSSDDTAQVLDALLAEDPRLRVIHLAHNQGKAIALRMG
AAAARSEYLVCIDGDALLDKNAVPYLVAPLIANPRTGAVTGNPRIRTRST
LIGRVQVGEFSSIIGLIKRTQRVYGQVFTVSGVVAAFRRRALADVGYWSP
DMITEDIDISWKLQLKHWSVFFEPRGLCWILMPETLRGLWKQRLRWAQGG
AEVFLKNMFKLWRWRNRRMWLLFLEYSLSITWAFTYLFSITLYLLGLVIT
LPPGIHVQSVFPPAFTGMVLALTCLLQFAISLVIERRYEPKLGHSLFWII
WYPMVYWMLNLFTTVVSFPKVMLITKRKRARWVSPDRGIGRVKS
>YPO3481 ibeB, probable outer membrane efflux lipoprotein
MFSRILILSLPALLAGCISLDPDYQRPVAPVPATLPYSTASSSKAADIPW
QETIIDPKLRQVIALALESNRDLRQAIADIEAARAQYGVQRAAQIPTVNA
GVNGSRGRGLSDTSDGNNNTAISQSYGAQASVSAFELDLFGKKSSLSHAE
FETYLATEEAAKTTRITLIADTATAWVTLAADQNQLLLAEETLKSAEQSL
KLAQLRQKNGIASRIDVAAMETLYQSARADVAQYKTTVAQDKNALDLLVG
QPVAAHLLPVTASTLPEVIKAVPVGLSSDVLLNRPDVLEAEHKLKSANAN
IGAARAAFFPSVTLTASGGVSSSALSTLLSEGAGIWSLAPAITLPIFDGG
ANRAALEYSQAQKTGYIAAYEKAIQTAFKEVADALARKATIQEQRAAQQA
YVAAAQESVELAQKRYKQGIDTYLNMLDAQRTLYAAQTRLIAVQQIQTNN
LITLYKVLGGGVSDVAKE
>YPO0495 imp, organic solvent tolerance protein precursor
MKKRFPTLLATLIWTALYSQHTLADLAEQCMLGVPTYDQPLVTGDPNQLP
VRINADKTEANYPDNALFTGNVIVQQGNSTLTANQVELTQVQKPGEVIPL
RTVTATGDVNYDDPQIKLKGPKGWSNLNTKDTDMDKGKYQMVGRQGRGDA
DLMKLRDQSRYTILKNGTFTSCLPGDNSWSVVGSEVIHDREEQVVEVWNA
RFKIGKVPVFYSPYMQLPVGDKRRSGFLIPNAKFTSNNGFEFLLPYYWNI
APNFDATITPHYMERRGLQWQNEFRYLLAPGSGTMALDWLPNDRIYTGPD
GTDKNATRWLYYWGHSGVMDQVWRFNINYTRVSDPAYFTDLTSQYGSTTD
GYATQIFTAGYANENWNATLSSKQFQVFTAAGNSNAYRAQPQLDMNYYKN
DVGPFDMHVYGQAAKFTSVNPTNPEASRFHIEPTVNLPLSNSWGSINTEA
KLLATHYQQDIPASFADNASNPKLKDSVNRVLPQFKVDGKVVFDRSMDWA
TGFTQTLEPRAQYLYVPYRNQDDIYIYDTTLMQSDYSGLFRDRTYSGLDR
IASANQVSTGLTSRIYDDARVERFNVSVGQIYYFSRSRTGNTEAIDNSNA
TGSLVWAGDTFWRINDQLGLKGGAQYDTRLGSLTLGNAIMEYRKDADRMI
QLNYRYASPKYIQAAVPKVYNPDYQQGISQVGTTASWPIADRWAIVGAYY
YDTKAKQPASQLVGLQYNTCCWAVNLGYERKITGWNAQGQTSKYDNKIGF
NIELRGLSGGHSLGTAQMLNSGILPYQSAF
>YPO2021 kdsA, 2-dehydro-3-deoxyphosphooctonate aldolase
MKQKVVSIGDINVANDLPFVLFGGMNVLESRDLAMRICEHYVTVTQKLGI
PYVFKASFDKANRSSIHSYRGPGLEEGMKIFQELKQQFGVKVITDVHEAS
QAQPVSEVVDVIQLPAFLARQTDLVEAMARTGAVINVKKPQFVSPGQMGN
IVEKFKEAGNDQVILCDRGSNFGYDNLVVDMLGINVMVQATGGHPVIFDV
THALQCRDPFGAASGGRRAQVAELARAGMAVGLAGLFIEAHPEPNSAKCD
GPSALPLDKLEPFLVQMKAIDDLVKSFPALDTSK
>YPO1400 kdsB, 3-deoxy-manno-octulosonate cytidylyltransferase
MSFIAIIPARYASTRLPGKPLADIAGKPMVVHVMERALASGADRVIVATD
HPDVVKAVEAAGGEVCLTRADHQSGTERLAEVIEHYGFADDDIIVNVQGD
EPLVPPVIIRQVADNLAACSAGMATLAVPIASSEEAFNPNAVKVVMDAQG
YALYFSRATIPWERERFAQSKETIGDCFLRHIGIYAYRAGFIRRYVNWAP
SQLEQIELLEQLRVLWYGEKIHVAVAKAVPAVGVDTQSDLDRVRAIMLNQ
>YPO0055 kdtA, 3-deoxy-D-manno-octulosonic-acid transferase
MLLRLYQVLLYLIQPLIWLRLLLRSRKAPAYRKRWGERYGFCAGKVVAGG
IMLHSVSVGETLAAIPLVRALRHRYPSLPITVTTMTPTGSERVQSAFGKD
VHHVYLPYDLPGSVNRFLDQVNPKLVIIMETELWPNLINTLHRRKIPLVI
ANARLSARSAAGYKKIGSFIRTILQRITLIAAQNQEDGDRFIELGLKRSQ
LTVTGSLKFDISVTPELAARAVTLRRQWAPHRPVWIATSTHDGEETILLE
AHRQLLQQFPTLLLILVPRHPERFGKAVELTQKIGLSYTLRSKGEVPSSS
TQVVIGDTMGELMLLYGIADLAFVGGSLVERGGHNPLEAAAHAIPVLMGP
HTFNFKDICAKLEQAEGLITVTDTLSLVKEITVLLTDEDCRLYYGRHAVD
VLHENQGALQRLLHLLEPYLPQRSH
>YPO0054 kdtX, lipopolysaccharide core biosynthesis glycosyl transferase
MGTKKRLSVVMITKNEASLLTDCLASVAWADEIIVLDSGSEDETRALAQQ
FGAKVYSNINWPGYGKQRQLAQQYASGDYILMLDADERVTPELKIAIESV
LLAPEEGAVYSCSRRNLFLGRFMRHSGWYPDRVTRLYPHHQYRYNDNLVH
ESLDSGSAKVIPLAGDLLHLTCRDFFAFQRKQLSYAEAWAIQRHQQGKSC
SYFAILSHTLGAFSKTWLLRAGFLDGKQGLLLAVVNAQYTFNKYAALWAL
SHQYQKSEKS
>YPO2716 lepA, GTP-binding protein LepA
MKHIRNFSIIAHIDHGKSTLSDRIIQICGGLSEREMAAQVLDSMDLERER
GITIKAQSVTLDYHSKDGQTYQLNFIDTPGHVDFSYEVSRSLAACEGALL
VVDAGQGVEAQTLANCYTAMEMDLEVVPVLNKIDLPAADPERVAEEIEDI
VGIDATDAIRCSAKTGVGVPDVLERLVRDIPAPEGDPNGPLQALIIDSWF
DNYLGVVSLIRIKNGSLRKGDKVKVMSTGQSYNADRLGIFTPKRVDRDVL
NCGEVGWLVCAIKDILGAPVGDTLTLTRNPAEKSLPGFKKVKPQVYAGLF
PISSDDYESFRDALGKLSLNDASLFYEPESSTALGFGFRCGFLGLLHMEI
IQERLEREYDLELITTAPTVVYEVITTNQETVYVDSPSKLPALNNIEELR
EPIAECHMLLPQEYLGNVITLCIEKRGTQTNMVYHGKQVALTYEIPMAEV
VLDFFDRLKSTSRGYASLDYNFKRFQTSDMVRVDVLINNERVDALALITH
RDNAQYRGRDLVEKMKELIPRQQFDIAIQAAIGNHIIARSTVKQLRKNVL
AKCYGGDVSRKKKLLQKQKDGKKRMKQVGNVELPQEAFLAILHVGKDSK
>YPO0784 lgt, prolipoprotein diacylglyceryl transferase
MSNSYLAFPKFDPVIFSIGPVSLHWYGLMYLVGFVFAMWLAVRRANKPGS
GWTKEEVENLLYAGFLGVFIGGRVGYVLFYNLPMFLDNPLYLFKVWDGGM
SFHGGLIGVICVMLWFARRTKRNFFQVADFIAPLIPFGLGAGRLGNFINA
ELWGRVTTDTPWAMLFPTSRNTDIAIVAADPAKWQAIFNQYGVLPRHPSQ
LYEMILEGVVLFIILNVFIRKPRPMGSVSGLFLIGYGTFRIIVECFRQPD
EQLGLFEGMISMGQILSVPMILAGIIMMIWAYRRPTQKLS
>YPO1377 lolA, outer-membrane lipoprotein carrier protein precursor
MKRLLVACCFLSGLISASALADASTDLQNRLSKVNSFHASFSQAVTSSDG
AVVQEGEGELWVKRPNLFNWHMTSPDESVLISDGETLWFYNPFVEQATAT
WLKNATGNTPFMLITRNNPDDWKQYNVKQKGDDFELTPKSASGNLKQFAI
SVTPSGTIKSFTAVEQDGQRSAYTLKSQQSSVVDASKFTFTPPKGVTLDD
QR
>YPO2015 lolB, outer membrane lipoprotein LolB precursor
MPMRKRHFYRLLPLASLLLAACTIPVSKGPATSPTSPQWRQHEQQLQQLG
QFETRGAFAYLSDKQKVYARFFWQQTSPERYRLLLTNPLGSTELELVVQP
GVTQLTDNQGKRYVSDDPQEMIQKLTGMSIPLESLRQWILGLPGDTSDFT
LDDKYRLKKLTYQQNGVTWVVDYQEYNTQVTPSLPSRLELNQDGQRIKLK
MDSWTIK
>YPO2394 lpp, major outer membrane lipoprotein
MNRTKLVLGAVILASTMLAGCSSNAKIDQLSSDVQTLNAKVDQLSNDVNA
VRADVQAAKDDAARANQRLDNQAQAYKK
>YPO1056 lpxA, UDP-N-acetylglucosamine acyltransferase
MIDKTAFIHPSSIVEEGAIIGAGVYIGPFCIVGSQVEIGAGTELKSHVVV
NGITKIGCDNQIYQFASIGEANQDLKYAGEPTRVEVGDRNRIRESVTIHR
GTTQGGGVTKVGCDNLLMVNTHVAHDCVIGNRCILANNAALGGHVEIDDY
AIIGGMTAIHQFCVIGAHVMVGGCSGITQDVPPFVIAQGNHATPFGINIE
GLKRRGFDKESLHAIRSAYKLLYRSGRTLDEVKPEIAELAEQYPVVKAFN
DFFARSTRGIIR
>YPO1057 lpxB, lipid-A-disaccharide synthase
MQNSPLTADCSLNAGRPLTIGLVAGETSGDILGAGLIRALKVQVPNARFV
GVAGPLMQAEGCEAWYEMEELAVMGVVEVLERLPRLLKIRKDLTQRFSEL
SPDVFVGIDAPDFNITLEGRLKQRGIRTIHYVSPSVWAWRQKRVFKIGKA
TDMVLAFLPFEKAFYDRFNVPCRFIGHTMADAMPLVPDQQAARAELGIAP
NATCLALLPGSRHSEVEMLSADFLRTAVILRDKLPNLEVVVPLVNSKRRE
QFERIKAEIAPDLSVHLLDGKARVAMIASDAALLASGTAALECMLAKCPM
VVGYRMKPFTFWLAERLVKTPYVSLPNLLAGEELVTELLQQECQPQKLAG
ALLPLLQGGSEIAALKERFLVLHQSIRCGADEQAAQAVLELADR
>YPO0561 lpxC, UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MRDKMMIKQRTLKRIVQATGVGLHTGKKVTLTMRPAPANTGVIYRRTDLN
PPVDFPADAKSVRDTMLCTCLVNEHDVRISTVEHLNAALAGLGIDNIIIE
VNAPEVPIMDGSASPFVYLLLDAGIEELNSAKKFLRLKETVRVEDGDKWA
ELSPFNGFRLDFTIDFNHPAIDSSTQRYCLDFSADSFVRQISRARTFGFM
RDIEYLQSRGLCLGGSFDCAIVVDDYRVLNEDGLRFEDEFVRHKMLDAIG
DLFMCGHNIIGAFTAYKSGHALNNKLLQAVLAKQEAWEFVTFQDEAEMPL
AFKAPSTVLAY
>YPO1054 lpxD, UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
MPSIRLADLAQQLDAQVHGDGDLVITGIASMHSAQPEQITFLSNSRYREQ
LASCNAGAVVLTEADLPFCKVAALVVENPYFTYARMAQIMDTTPQPAQDI
APSAVISPQATLGEGVSVGANAVIESGVVLGDNVVIGAGCFIGKNTHIGA
GSRLWANVSIYHEVVIGQNCLIQSGTVIGADGFGYANDRGNWVKIPQLGS
VHIGDRVEIGACTTIDRGALDNTIIGNGVIIDNQCQIAHNVVIGDNTAVA
GGVIMAGSLKVGRYCMIGGASVINGHMEICDKVTITGMGMVMRPITEPGL
YSSGIPLQPNKMWRKTAALVMNIDGINKRLKAVERKIDKE
>YPO1396 lpxK, tetraacyldisaccharide 4'-kinase
MIERIWSGQSRLYLLLLPLSWLYGAVTWLIRASYRLGLRSAWRSPVPVII
VGNLTAGGNGKTPVVIWLVEQLQQRGYRVGVVSRGYGGKSAVYPLLLSDN
TTTAQAGDEPVLIFQRTGAPVAVSPKRADAIKALLQSHAVDFIITDDGLQ
HYALQRDFELVVIDGVRRFGNGWWLPAGPMREREGRLRSVDAAITNGGLA
AEGEIPMQLVAREAVNLVTGQRQPAEQLQHVVAMAGIGHPPRFFATLNLL
GIKPENEHAFADHQDYSLAQLSRLTSGPQILLMTEKDAVKCRAFALPNWW
YLPVDAQLPSDRADKLLLNIQALSPDTK
>YPO0476 lspA, signal peptidase II
MNKPICSTGLRWLWLAVVVVILDISSKQWVMAHFALYESVPLIPFFNLTY
AQNFGAAFSFLADKSGWQRWFFAGIAIGISVVLMVMMYRSTAKQRLINCA
YALIIGGALGNLYDRLVHGAVNDFLDFYINNWHFPTFNLADVAICIGAAL
VIFEGFLSPVEKNAVNNDE
>YPO0477 lytB, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MQILLANPRGFCAGVDRAISIVERAIEMYGAPIYVRHEVVHNRYVVESLC
ERGAIFIEEISEVPDGSILIFSAHGVSQAVRAEARSRNLTMLFDATCPLV
TKVHMEVARASRKGKEAILIGHAGHPEVEGTMGQYSNPNGGMYLVESPDD
VWQLNVKDENNLCFMTQTTLSVDDTSAVIDALNTRFPKIVGPRKDDICYA
TTNRQEAVRNLANDADIVLVVGSKNSSNSNRLAELVQRMGKPAYLIDSAA
DIQEFWLQGAKCIGVTAGASAPDILVQQVIARLKDLGAGESIELSGREEN
IVFEVPKELRVEVKQID
>YPO2752 mepA, penicillin-insensitive murein endopeptidase
MKNWIVGMVALVTMVPVMAATPWQKITHPVAGSPQSIGGFANGCVIGAQP
LPLESADYQVMRSDQRRYFGHPDLLNFIHRLSAQTHQQQLGTVLIGDMAM
PAGGRFSSGHASHQSGLDVDIWLQLPKQRWSQQQLLKPQPIDLVAVDGKR
VIPALWQPQIESLIKLAAKDNDVTRIFVNPAIKKQLCLDAGADRQWLHKV
RPWFAHRAHMHVRLRCPANSLECVDQDTPPPGDGCGAELESWFQPPPPSA
KPGKTLPPPLPPSCQALLDNHFATE
>YPO2957 mltB, putative membrane-bound lytic murein transglycosylase B
MVYRYSMRYLAVILPLLTLLSACSSQPTPPVAATPSDSPVQGGFLLEPEH
TGQLQNGDFAFNPDTTRFVDKMVREHGFDRQQLHDVLAQTQRLDWVIRLM
DKQAPTSRPPSEPNGAWNRYRNKFITPDNVQNGVVFWNQYEGALQRAWEV
YGVPPEIIVGIIGVETRWGRVMGKTRIIDALATLSFAYPRRATFFTGELE
TFLLMARAEGKDPLSLRGSYAGAMGYGQFMPSSFKRYAVDFDGNGHINLW
DPVDAIGSVANYFKSHGWTKGAPVAVPANGQAPNLENGFKTRYPISTLAA
AGLSPKGSLGDYQEASLLRFDVGTGYQYWYGLPNFYTITRYNHSTYYAMA
VWQLGEAVGRARKGESMITQ
>YPO0954 mltC, membrane-bound lytic murein transglycosylase C
MACKMKKILALLVIAPLLVSCSGNKNQVENEVFVKDTNGFEILMGQFAHN
IENIWGLKEVLIAGPKDYVKYTDQYQTRSHINFDAGTITIETIATTNPAA
HLRQAIITTLLMGDDPGSIDLYSDVNDIQISKEPFLYGQVLDNNGEPIRW
EWRAAHFADYLLQNKMQTRTSGLHVISFVTIQLVPNHLDKRAHKYLPLVR
KSAARYGVEESLILAIMQTESSFNPYAVSRSDALGLMQVVQHTAGKDVFK
LKGKSGQPSRSYLFDPENNIDAGTAYLSILQNTYLGGIQNATSRRYAVIT
SYNGGAGSVLRVFHSDKNKAVGIINTMSPGDVFQTLTTKHPSGESRRYLV
KVNSAQKNYRRY
>YPO1078 mltD, membrane-bound lytic murein transglycosylase D precursor
MIARLLSNHIDTHMKTKAILLASVLLVGCQTSKQDAQAPEQHAQSLSSAG
QASEAGEYTNSTREGSARWLESESSYAQQDLWNFIKDELKMKVPENSRIR
EQKQKYLKNKSYLHDVTLRAEPYMYLIVEQIKKRKMPMELVLLPIVESAF
DPHATSSANAAGLWQIVPSTGRNYGLKQNQWYDGRRDVVASTKAALDILE
RLNKMFNGDWLLTVAAYNSGEGRVMQAIKANKAKGKPTDFWALSLPRETS
IYVPKMLALGDLLKNSKKYGITLPETDKDRALARVDVDQQIELTQAAEMA
GMSLTKLKSFNSGYKRNVTAPDGHGPRYIMLPKAHAEQLKDSLADTDITA
VQPTKLATNSTKSASSSQYKVRPGDTLSTIAKRLNIKTSDLQSWNNLRAK
STLKVGQTLQLASNTTSKSITYQVRKGDSFASIAKRHGVNTDDVMRWNSV
VSKANNLQPGLKLTLFVNDKSTPEA
>YPO3519 mpl, UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl- me so-diaminopimelate ligase
MRIHILGICGTFMGGLAMLARSLGHEVTGADANVYPPMSTLLENQGIDLI
QGYDPAQLNPIPDLVIIGNAMTRGNPCVEAVLEQGIPYVSGPQWLHDHVL
PERWVLAVAGTHGKTTTAGMLAWILEACGYEPGFVIGGVPGNFDVSARLG
NSPFFVIEADEYDCAFFDKRSKFVHYSPRTLIMNNLEFDHADIFDDIKAI
QKQFHHLVRLVPGKGKIILPDNDNHLKQVMAMGCWSEQELVGETGSWFAR
KVSTDASVYEVLLDNNVVGEVNWSLVGEHNMHNGLMAIAAARHVGVLPAD
ACRALGDFINASRRLELRGEAHGVTVYDDFAHHPTAILATLAALRSKVGG
TARILAVLEPRSNTMKLGLCKNELAPSLGRADEVFLFQPQHIPWQVVEVA
EACIQPAYWSADIDQLVDMIVKTAQPGDHILVMSNGGFGGIHDKLLSALD
KKAEQATALF
>YPO0547 mraW, S-adenosyl-methyltransferase
MVDNNKTVDNNYKHTSVLLDEAVKGLNIRDNGIYIDGTFGRGGHSRLILS
QLGPEGRLIAIDRDPEAIEAAKQITDPRFSIVHGPFSDLAHYVRDLDLVG
RIDGILLDLGVSSPQLDDAERGFSFMRDGPLDMRMDPSRGLSAAEWLMKA
SADDIAWVLKTFGEERFAKRLAKAIVERNLTQPMTRTKELADLIANASPF
RDKHKHPATRSFQAIRIYINSELEEIERALDGAHEVLAPEGRLSVISFHS
LEDRIVKNFIRHHSRGPQVPAGLPLTEAQLRSMGGRTLKSVGKMMPGDAE
IAENPRARSSVLRFAERIGE
>YPO0552 mraY, phospho-N-acetylmuramoyl-pentapeptide-transferase
MLVWLAEYLVKFYSGFNVFSYLTFRAIVSLLTALFISLWMGPHLIAWLQK
LQIGQVVRNDGPESHFSKRGTPTMGGLMILFSITISVLMWAYPSNPYVWC
VLFILIGYGIVGFIDDYRKVVRKNTKGLIARWKYFWQSIIALAAAFTMYS
IGKDTSATELVVPFFKDIMPQLGLLYVLLAYFVIVGTSNAVNLTDGLDGL
AIMPTVFVAAGFALVAWATGNVNFAAYLHIPYLRHAGELVIVCTAIVGAG
LGFLWFNTYPAQVFMGDVGSLALGGALGTIAVLLRQEFLLVIMGGVFVVE
TLSVILQVGSFKLRGQRIFRMAPIHHHYELKGWPEPRVIVRFWIISLMLV
LIGLATLKVR
>YPO0145 mrcA, penicillin-binding protein
MKFVKYFLILAVCCILLGAASIFGLYKYIEPQLPDVATLKDIRLQTPMQV
YSAEGELIAQFGEKRRIPLTLNQIPPEMVHAFIATEDSRFYDHHGVDPVG
ILRAVSIAMLSGRASQGASTITQQLARNFFLSPERTLMRKIKEAFLAIRI
EQMLTKDEILELYLNKIYLGYRAYGVGAAAQVYFGKEVHELTLSQIAMIA
GLPKAPSTFNPLYSHDRAVARRNVVLLRMLDEKYITQAQYDQARSEELVA
NYHVPQIAFSAPYLAEMVRQEMIKRYGENAYTDGYQVYTTITRKLQLAAV
DSLRANVLAYDMRHGYRGPSNVLWKVGESAWSREQIIDSLKALPVYGPLL
PAVVTEADAAQATAMLADGSNVTLPMVGIRWARPFKSDNAQGPVPKKATD
VVQPGQQIWVRKVDDNWWLAQVPDVNSALVSIDPNNGAIKALVGGFDFNQ
SKFNRATQALRQVGSNIKPFLYTAAMDKGLTLATILNDLPITRWDSGAGT
DWRPKNSPPTYDGPIRLRQGLGQSKNVVMVRAMRAMGVDYAAEYLQRFGF
PAQNIVHSESLALGSASFTPLQLVRGYAVLANGGYLVDPYFITKITDDVG
NVLFETKPKVVCDNCNLPVIYGDTQRSVVLSDDNIENVATSQNQNASNVP
MPELEQVTPAQTTLNSEQQYAPHVISTPLAFLMRDALNSNIFGEPGWMGT
GWRAGRDLKRKDIGGKTGTTNSSKDAWFSGYGPDTVTSVWIGFDDHRRNL
GRSTASGAIPDQISGAEGGAKTAQPAWNDFMKVALEGLPEKQVPPPPGIV
SVVIDKQTGKLSNGGPGSRSEYFIDGTQPTEHTVHEVGTTLMDNGQTHEL
F
>YPO3393 mrcB, penicillin-binding protein 1b
MSGDDREPIGRKGKKAQPKAAPKRPLRRRRDEDEYEEDYDEEQNDYDDEE
EPMPRKVASRPPRKKRRWLGLLIKLFLIGAVALAIYGVYLDSQIRSRIDG
KVWQLPAAVYGRMVNLEPGMSYSKKEMIALLEGMQYRQVSRMTRPGEFTV
QNDSIDILRRPFDFPDGKEGQIRARLLFKNDRLAQIQNLDNQRDFGLFRL
DPKLITMLQSPNGEQRLFVPRAGFPDLLVDTLLATEDRHFYEHDGVSPYS
IARAVVANLTAGKAVQGGSTLTQQLVKNLFLTNERSLVRKLNEAYMALLM
DYRYSKDRILELYLNEVYLGQSGGDQIRGFPLGSLYYFGRPVDELSLDQQ
AMLVGMVKGASLYNPWRNPKLALERRNLVLRLLQNQGIIDAELYTMLSAR
PLGVQPKGGVITPQPAFMQMVRQELQQKLGNKVNDLSGVKIFTTLDPVSQ
DAAEKAIEDGVPALRAARNMNDLEAAMVVVDRFSGEVRAMVGGSQPQFAG
FNRAMQARRLVGSLAKPPTYLAALSEPDKYRLNTWLSDQPLSLKLSNGSL
WQPKNYDRQFRGQVMLMDALVNSLNIPTVNLGMSVGLDQISATLQRLGIP
KSVINPVPAMLLGAIDLTPVEVAQEYQTIASGGNRAPLSAVRSVIAEDGT
VLYQSFPQAERMVPAQASYLTLYAMQQGVVRGTSRSLSAKFGKYNLAAKT
GTTNDLRDSWFAGIDGKEVTIAWIGRDNNGPTKLTGASGALTLYRRYLEN
QTPLPLILQPPEGISQMNIDSAGNFVCGEGSGMRVIPVWTENPQALCQGS
TPTQDPTKPNDDGVADWIKEMFGQ
>YPO3666 mreC, rod shape-determining protein MreC
MKPIFSRGPSLQLRLFFAIIAAIVLVIADSRLGTFVKIRTYMDTAVSPFY
FLANGPRKILDNVSDTLATREQLELENRALRQELLLKNTDLQLLGQFKQE
NNRLRELLGSPLRQDEQKMVTQVMSSGTDPYSDHVVIDKGSNSGVYEGQP
VISDRGVVGQVVAVSKFTSRVLLICDASHALPIQVLRNDIRVIAAGSGCS
DDLLLEHLPSNTDIRVGDVLVTSGLGGRFPEGYPVAVVSSVKVDNQRAYT
VIQARPTADLQRLRYLLLLWGADRNGDMPMPPDEVRRVANERLAPMMSQV
LPSADAMGPPAPAASTPAGATPGVVTPGVSP
>YPO3667 mreD, rod shape-determining protein MreD
MNRYSSHGRWVIWLSFLIAMVLQIMPWPEQIYMFRPSWLALVLIYWVMAL
PHRVNVGTGFILGLIMDLILGSTLGVRALAFSIIAYLVAFKFQLFRNMAL
WQQALIVMLLSLTMDVVVFWSEFLVINVAFRPEVFWSSVVNGILWPWLFL
LMRKIRRQFSVQ
>YPO2063 msbB, lipid A biosynthesis lauroyl acyltransferase
MHKEKNDATGFIPVFQKTFLHPRFWGVWLGAGAIAALAYIPPKFRDPLLA
GIGRLAGKFAKSARRRARINLLYCMPELPESEREHIIDQMFATAAQPLMM
MAELCFRDPKKVLTRVHWHGQEILDELQQQERNVILLVPHAWSIDIPAML
LAEQGKPVAGMFHHQRNPLVDYLWNSARLHFGGRIHARESGIKPFISSVR
QGFWGYYLPDEDYGPEQSEFVDFFATYKATLPAIGRLMKVCRAAIVPMFP
VYNYREHRLDIYIRPPMDDLADADDAYIARRMNEEVELLVKPNPEQYTWI
LKLLKTRKEGETEPYVRKDL
>YPO0238 mscL, large-conductance mechanosensitive channel
MSFMKEFREFAMRGNVVDLAVGVIIGAAFGRIVSSLVADIIMPPLGLLLG
GVDFKQFHFVLRAAEGTIPAVVMNYGTFIQSIFDFVIVALAIFSAVKLMN
KLRREKAEEEPATPPAPTTEEILLAEIRDLLKAQHTK
>YPO3552 mtgA, monofunctional biosynthetic peptidoglycan transglycosylase
MISVRRGFSQLWYWGKRGVIGIIALWMAGILIFAFLPVPFSMVMIERQLG
AWLTGDFAYVAHSDWVPMDEISPYMALAVMAAEDQKFPDHWGFDVGAIES
ALSHNQRNQKRIRGASTLSQQTAKNVFLWDGRSWVRKGLEVGLTAGIELI
WTKRRILTVYLNIAEFGNGIFGVEAAARHFFNKPASKLSASEAALLAAVL
PNPLRFKVNAPSGYVISRQQWILRQMHQLGGKTFLQENTLD
>YPO3569 murA, UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MDKFRVQGRTRLSGEVTISGAKNAALPILFAALLAEEPVELQNVPKLKDI
DTTIKLLSQLGTKIERNNGSVFVDASAVNEFCAPYDLVKTMRASIWALGP
LVARFGQGQVSLPGGCAIGARPVDLHITGLEQLGAEIKLEEGYVKASVNG
RLKGAHIVMDKVSVGATVTIMSAATLAEGTTVIENAAREPEIVDTANFLN
TLGAKISGAGTDRITIEGVTRLGGGVYRVLPDRIETGTFLVAAAISGGKV
VCRQTRPDTLDAVLAKLREAGADIEVGDDWISLDMQGKRPKAITFRTAPH
PGFPTDMQAQFSLLNLVAEGTGVITETIFENRFMHVPELIRMGAHAEIES
NTVICYGVEQLSGAQVMATDLRASASLVLAGCIAEGVTIVDRIYHIDRGY
ERIEDKLRALGAKIERVKGE
>YPO3760 murB, UDP-N-acetylenolpyruvoylglucosamine reductase
MSNQRSSLKHLNTFALPAYASNVISAGSVETLIAAWHESKAKRQPVLLLG
EGSNVLFIKNFSGTVLLNRIMGITSTEDSAAWYLHVGAGENWHQLVCHSL
QNNMPGLENLALIPGCVGSAPIQNIGAYGVELKQVCEYVDLLDMDKGTIQ
RISAEECQFGYRDSIFKHRYGNGFAIVSVGIKLMKSWTPTLGYGDLIHMD
PLTVTATDIFNSVCTMRRSKLPDPMVTGNAGSFFKNPVVSAAIAEEIVHC
YPNAPHYLQPDGSVKLAAGWLIDQCSLKGYQIGGAAVHQQQALVLINQSE
ATGQDVIHLARYIRQQVAQRFSIWLEPEVRFIADNGEVNAVEHLS
>YPO0556 murC, UDP-N-acetylmuramate--L-alanine ligase
MNTQQLAKLRTIVPEMRRVRHIHFVGIGGAGMGGIAEVLANEGYQISGSD
LAPNSVTQHLTALGAQIYFHHRPENVLDASVVVVSTAISADNPEIVAARE
ARIPVIRRAEMLAELMRYRHGIAVAGTHGKTTTTAMLSSIYAEAGLDPTF
VNGGLVKAAGTHARLGSSRYLIAEADESDASFLHLQPMVAIVTNIEADHM
DTYQGDFENLKQTFINFLHNLPFYGRAVMCIDDPVVRELLPRVGRHITTY
GFSDDADVQIASYRQEGPQGHFTLRRQDKPLIEVTLNAPGRHNALNAAAA
VAVATEEGIEDEDILRALVGFQGTGRRFDFLGNFPLAPVNGKEGSAMLVD
DYGHHPTEVDATIKAARAGWPDKRIVMLFQPHRYTRTRDLYDDFANVLSQ
VDVLLMLDVYAAGEPPIPGADSRALCRTIRNRGKLDPILVPDSESAPEML
AQILNGEDLILVQGAGNIGKIARKLAEHKLQPQLKDEEHHG
>YPO0553 murD, UDP-N-acetylmuramoyl-L-alanyl-D-glutamatesynthetase
MVDYQGKKVVIIGLGLTGLSCVDFFIARGVTPRVMDTRINPPGLDQLPES
VEQHVGDLNQEWLLDADLIVVSPGMALAHPALSEAAEAGVEIIGDIELFC
RENQAPVVAITGSNGKSTVTTLVGEMAKAAGWSVGGGGNIGVPALTLLKQ
DNQLTVLELSSFQLETTHSLRASAATILNVTEDHTDRYPLGLQQYRAAKL
RVYENAKVCVVNADDALTMPVRGADSRCISFGVDVGDYHLNKQQGEIWLR
VRGEKVLNTREMKLSGRHNYTNALAALALADAVGIPRASSLKALTTFSGL
PHRFQLVLERHGVRWINDSKATNVGSTEAALDGLQVDGTLHLLLGGDGKS
ADFSGLTHFLQGDRIKVYCFGRDGGQLAALRPDVSQLTETMAQAMALVAK
VVLPGDRVLLSPACASLDQFRSFEHRGNEFARLAEELG
>YPO0550 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MRDLFAPWGLDVPERALREMTLDSRIAAAGDLFVAVVGHQTDGRRYIPQA
IAQGVAAIVAEADGVAPDVSVAEIHGVPVIYLRNLNQHLSTLAGQFYHQP
GAALRLVGVTGTNGKTTTTQLLAQWSQALGETSAVMGTVGNGLLGQVIPT
ENTTGSAVDIQHLLRNLVDQGATFAAMEVSSHGLIQDRVAALSFAAVVFT
NLSRDHLDYHGNMTSYEAAKWLLFSTHQSEHKIINADDDVGRRWLSQLPQ
AVAVSMAGNVPKGWNGPWLSANKVIYHDNGASIAFDSSWGEGELESRLMG
AFNVSNLLVALATLLVQGYPMAQLLAAAPHLQPVCGRMEVFNAPGKPTVV
VDYAHTPDALEKALAAARLHCTGKLWCVFGCGGDRDKGKRPLMGGIAEQL
ADCVVVTDDNPRSEEPQAIVADILSGLLDAGRVQAIHGRAEAVTSAIMQA
KEDDVVLIAGKGHEDYQLVGNRRLDYSDRVTVARLLGGQA
>YPO0551 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diamino pimelate--D-alanyl-D-alanyl ligase
MIKVSLRFLASLLNAEYIVAESVSDDIEITEVTIDTRKVTAGCLFVALKG
ERFDGHDFAEDAIAAGAGALLVSKRLLVGGPQLVVKDTRLALGQFAAWVR
QQVPARIVALTGSSGKTSVKEMAAAILRQCGNVLYTAGNFNNDIGVPLTL
LRLTAEHDFAVIELGANHVGEIAYTTDLSRPESALVNNLAAAHLEGFGSL
AGVAQAKGEIFAGLPANGTAIINADSNDWPHWQETLHNKRVWRFSPHAAE
HIDFYASDVRITPQLTSFTLHSPFGTVAIELPLPGQHNIANALAAAALAM
SVGADLAAVRQGLAQLQAVPGRLFPVPLAEGQLLLDDSYNANVGSMIAAA
QVLAEMPGYRVMVVGDMAELGETAADCHRQVGEAAKLAGVDKVLSVGTLS
QILSSASGNGEHFQDQNTLSTRVNALLNEYPVITVLIKGSRSAAMENVVR
ALQEKASC
>YPO0555 murG, N-acetylglucosaminyl transferase
MSGKTKRLMVMAGGTGGHVFPGLAVAHHLMAQGWQVRWLGTADRMEASLV
PQHGIEIDFIKISGLRGKGLMAQLTAPIRIYRAVRQAQKIMRDYQPNVVL
GMGGYVSGPGGLAAWLCGVPVVLHEQNGIAGLTNRWLARIAKKVLQAFPG
AFPNADVVGNPVRTDVLALPLPAVRLSGREGPIRVLVIGGSQGARILNQT
LPLVAASLGEQITLWHQVGKGALPEVSQAYQQAGQAGHLVVEFIDDMAAA
YAWADVVVCRSGALTVSEVAAAGLPAIFVPFQHKDRQQYWNALPLEKAGA
AKIIEQPQFTATSVSSLLASWDRATLLSMAERARSVAIPDATERVAAEVV
AASKSA
>YPO3909 murI, glutamate racemase
MATKPQDANTTSREAITSKADSPPRPTALIFDSGVGGLSVYQEIRQLLPD
LHYIYAFDNVAFPYGEKSGEFIVERVLEIVTAVQQRHPLAIVVIACNTAS
TVSLPALRERFAFPVVGVVPAIKPAVRLTRNGVVGLLATRATVHASYTLD
LIARFATDCKIELLGSSELVEVAETKLHGGVVPLEVLKKILHPWLSMREP
PDTIVLGCTHFPLLTEELAQVLPEGTRMVDSGAAIARRTAWLISSQENVI
SSQDENIAYCMALDEDTDALLPVLQSYGFPKLQKLPI
>YPO2415 nlpC, putative lipoprotein
MRTRFWIFLISMVLAGCSSHTPTPSGYLSDSIVVVAKLNEQLRQWEGTPY
RNGGLDQRGVDCSGFVYRTFRDRFDMQLPRTTLAQTTLGTKVSRDELMPG
DLVFFKTGSGQNGLHVGIYDTNDEFIHASTSKGVIRSSLENVYWKRVYWQ
ARRI
>YPO3356 nlpD, lipoprotein
MSTGSPMIRLRRVAACTVVSLWLVGCTNDNSTSAPISSVGGDRSGTMLSK
ANTDSSGGRIVYNRSYDNIPKGSYSGNTYTVKRGDTLFYIAWITGNDFRD
LAAKNNIAEPYSLNVGQSIQLGNGSGGGMLAATDATSSGIAQPPSNIQNT
TTIQNTTTTVDSQSTSAYSGNSGKQNVGKMLPSSGAVVATTAPVTAPSSS
VSEPASNGGPVSGWRWPTDGKTIDSFSASEGGNKGIDIAGSRGQPILATA
SGRVVYAGNALRGYGNLIIIKHNDDYLSAYAHNDTMLVREQQEVKAGQKI
ATMGSTGTSSVRLHFEIRYKGKSVNPLRYLPQR
>YPO1435 ompA, putative outer membrane porin A protein
MKKTAIALAVALVGFATVAQAAPKDNTWYTGGKLGWSQYQDTGSIINNDG
PTHKDQLGAGAFFGYQANQYLGFEMGYDWLGRMPYKGDINNGAFKAQGVQ
LAAKLSYPVAQDLDVYTRLGGLVWRADAKGSFDGGLDRASGHDTGVSPLV
ALGAEYAWTKNWATRMEYQWVNNIGDRETVGARPDNGLLSVGVSYRFGQE
DAAAPIVAPTPAPAPIVDTKRFTLKSDVLFGFNKANLKPEGQQALDQLYA
QLSSIDPKDGSVVVLGFADRIGQPAPNLALSQRRADSVRDYLVSKGIPAD
KITARGEGQANPVTGNTCDNVKPRAALIECLAPDRRVEIEVKGYKEVVTQ
PQA
>YPO1222 ompC, outer membrane protein C, porin
MKLRVLSFIIPALLVAGSASAAEIYNKDGNKLDLYGKIDGLHYFSDNKNL
DGDQSYMRFGLKGETQITDQLTGYGQWEYQVNLNKAENEDGNHDSFTRVG
FAGLKFADYGSLDYGRNYGVLYDVTSWTDVLPEFGGDTYGADNFLSQRGN
GMLTYRNTNFFGLVDGLNFALQYQGKNGSSSETNNGRGVADQNGDGYGMS
LSYDLGWGVSASAAMASSLRTTAQNDLQYGQGKRANAYTGGLKYDANNVY
LAANYTQTYNLTRFGDFSNRSSDAAFGFADKAHNIEVVAQYQFDFGLRPS
VAYLQSKGKDIGIYGDQDLLKYVDIGATYFFNKNMSTYVDYKINLLDKND
FTKNARINTDDIVAVGMVYQF
>YPO1205 ompC2, outer membrane protein C2
MKRNILAILIPTLLVATTSHAAEIYNKDGNKLDLYGKVKALHYFSDNTKS
DGDKSYVRLGFKGVTQITDELSGYGQWEYNFAANYAESQEAKDNKTRLAF
AGLRYGNLGSIDYGRNYGVLYDIAAWTDMLPEFGNDSYTRTDNFMTGRTT
GVATYRNTDFFGLVDGLKFSLQYQGKNGAEGETNNGRTDTSKQNGDGFGL
SSSYEIGAGVSVGAAYASSNRTLAQKNSTFGKGDKADAWTTGLKYSDNGV
YLAANYAETRNMTPISGTAVINNVSTSVSGFANKTQNIELVAQYLFDFGL
KPSIAYIQSKGKDIEGIGDTDLVKYVDIGATYYFNKNMSTYVDYKINQLN
DDNKLKLNTDNVVALGLVYQF
>YPO1053 ompH, cationic 19 kDa outer membrane protein precursor
MKKWLCAASLGLALAASASVQAADKIAIVNVSSIFQQLPAREAVAKQLEN
EFKGRATELQGMERDLQTKMQKLQRDGSTMKASDRTKLENEVMKQRETFS
TKAQAFEQDNRRRQAEERNKILSRIQDAVKSVATKGGYDVVIDANAVAYA
DSSKDITADVLKQVK
>YPO2201 ompW, hypothetical protein
MKKITLALLAVASLVPTAASAHEAGDYIFRAGTATVRPNAGSDDVLGNGS
FKVDNNTQLGLTFSYLITDNIGVELLAATPFNHKVGLAGVGTIADVKQLP
PTLMAQYYFRDKQDKLRPYLGIGLNYTKFFDEKFNATGSDIGLTNLSVKD
SWGVAGQAGMDYMVSENWMLNMSVWWMNIESDVKFNLAGEEHSINTRLAP
WVFMFGAGYRF
>YPO2506 ompX, outer membrane protein X
MKKIACLSAVAACVLAVTAGSAFAGQSTVSGGYAQSDYQGVANKSSGFNL
KYRYEWSDSQLGYITSFTHTEKSGFGDEAVYNKAQYNAITGGPAYRINDW
ASIYGLVGVGHGRFTQNESAFVGDKHSTSDYGFTYGAGLQFNPAENVALD
VSYEQSRIRNVDVGTWVAGVGYTF
>YPO1125 pal, peptidoglycan-associated lipoprotein Pal
MQLNKVLKGLMLALPVLAVAACSSNKSANNDQSGMGAGTGTENGSNLSSE
EQARLQMQELQKNNIVYFGFDKYDIGSDFAQMLDAHAAFLRSNPSDKVVV
EGHADERGTPEYNIALGERRASAVKMYLQGKGVSADQISIVSYGKEKPAV
LGHDEAAFAKNRRAVLVY
>YPO2604 pbpA, penicillin-binding protein 2
MKKEPNPFRDYSAESALFVRRAVVAFLGILLLSGVLVANLYNLQIIRFDD
YSTRSNDNRIKLVPIAPSRGMIFDRNGTPLALNRTIYQLELMPEKIENLS
ATLNALRPIVDLTDDDIANFEKERKRSRRFTSIAVKTPLTEVQVARFAVN
QFRFPGIEVKGYQRRFYPYGSALTHVIGYVSKINDKDVERLDKEGILPNY
AATHDIGKLGIERYYESTLHGKTGYEEVEVNNRGRVIRQLHEQPPQAGKD
IYLTLDLSLQIYIEKLLSGSRAAVVVTDPRTGGILALVSNPSYDPNLFVD
GISNKDYQGLLNDTNRPLINRATQGVYPPASTVKPYIAVSALSAGVITKN
TSLFDPGWWQLPGSEKRYRDWKKWGHGRLNVTKALEESADTFFYQVAYDM
GIDRLSSWMSKFGYGEYTGIDLSEERAGLMPTREWKQKRHKKPWYQGDTI
PVGIGQGYWTATPIQMAKSLMTLINDGTVKTPHLLQSTRIDGVLVPYKQE
DSTQIGSINSGYWEIAKDGMYGVANRPNGTGRKFFEGTPYKAAAKSGTAQ
VYSYETYNASKVAEHLRDHKLMVAFAPYENPTVSVAIILENGGAGPAVGT
ITRQILDHILLGDNNTELPDAVPLPPGVEAD
>YPO1176 pbpG, penicillin-binding protein 7 precursor
MYVKIRFALLSFLLLSTGISVAPLAIARGSAVEVKGTAPLELASGSAMVV
DLQTNKVIYANNADKVVPIASITKLMTAMVVLDAKLPLDEILSVDIDQTK
ELKGVFSRVRVNSEISRKDMLLLTLMSSENRAAASLAHHYPGGYNAFIKA
MNAKAKSLGMNSTHYVEPTGLSINNVSTARDLAKLLMATKQYPLIGQLST
TTEKMATFREPNYTLPFRNTNHLVYNDKWNIQLTKTGFTNQAGHCLVMRT
VIGKRPVALVVLDAFGKYTHFADANRLRSWIETGKAAPIPGAAKSYRQQK
DSQGRLAQVSE
>YPO3646 pcp, outer membrane lipoprotein
MNKLAIAVALAATVLSGCANNTASGDTFTASQARQVQTVTYGSIVSARPV
TIQGGNNNNVAGAIGGAVVGGFLGNTIGGGRGNSLATAGGAVAGGVAGQG
IQSAMNRSEGVQLEIRRDDGSNIVVVQAQGPTRFSAGQRVIIASDRSGTV
TVSPR
>YPO1231 pla2, putative outer membrane-associated protease
MNKEALAKKGAGALALLILSHPAVANNNTDTAGNVTVSTSLGLLNAESIE
SVYQSSEPNQKLSQLNWEANNTPIVKMDIAWDALPRLTLTAKGWSTLSSG
QGVMDNYDWLTPQQTQWSDWSHHEKTNLNYANEIDINAKIWFLKQHNYRV
GPILGYQENNQSWTAYGGNFNYNNGANIFTAPDGIVGVGYKQKFDMLYIG
LAGSYRYQQLEFNALLKYSNWVNANAYDNHYNRKVSFKDSSKNSSYYSAV
IDVGYYFTENTKLFVEAAWNQYSEGRGETQTLNYATGNVGSSKSGIEYQS
QTLTVGFQYKF
>YPO3834 pldA, phospholipase A
MARFWQILIALLLVPTLAQAEEATIEKIHDAPAVRGSIIAAMLQDHDNPF
LLYPYETNYLLYTYTNEINKQAISSYDWAEQANKDEVKFQLSLAFPIWRG
IAGDNSLLGASYTQRSWWQASNSEESSPFRETNYEPQLFLAWSTDYELAG
WTFREVEFGFNHQSNGKADPTSRSWNRVYTRVMAQRGNLEIDLKPWYRIP
ESDSKDDNPDITKYMGYYRLKVGYALGDSVFSLDGRYNWNTGYGGAEMGW
SYPITKHVRFYTQVFSGYGESMIDYNFRQTRVGVGIMLNDVL
>YPO2421 pmrF, probable glycosyl transferase
MSLNEPIKKVSIVIPVYNEQESLPALIDRTTAACKLLTQAYEIILVDDGS
SDNSTELLTAAANDPDSHIIAILLNRNYGQHSAIMAGFNQVSGDLIITLD
ADLQNPPEETPRLVHVAEEGYDVVGTVRANRQDSLFRKTASRMINMMIQR
ATGKSMGDYGCMLRAYRRHIVEAMLHCHERSTFIPILANTFARRTTEITV
HHAEREFGNSKYSLMRLINLMYDLITCLTTTPLRLLSLVGSAIALLGFTF
SVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEQTENNQDVEK
>YPO3112 prt, paratose synthase
MKILITGVSGYLGSQLANALMLEHEVVGTVRAGSVCNRITDIGNVNLINV
TDSGWIDKVLSFSPDVVINTAALYGRKGELLSELVDANIQFPLRILEMLV
STGKGLFFQCGTSLPADVSQYALTKNQFTELAREYCNKFSGKFIELKLEH
FFGPFDDSTKFTTYVINSCRSHSDLKLTAGLQRRDFIYINDLINAFKIMI
SKSESLISGESISIGSGHAVTIKEFVETVAKMTSYQGNLQFGAIPTRENE
LMYSCASLARIQELGWLCQYSLNSAIKDTLNRMRV
>YPO0056 rfaC, lipopolysaccharide heptosyltransferase-1
MHVLIVKTSSMGDVLHTLPALTDAMNAIPGIRFDWVVEEGFSQIPSWHPA
VDKVIPVAIRRWRKNWFGSDTRQERCDFKRVVQQRSYDRVIDAQGLIKSA
ALITRIAKGTKHGPDCKSAREPFASWFYNCRHEIDTKQHAVERIRQLFAK
SLGYDKPESYGDYAIAQRFLNQLPADAGQYLVFLHATTRDNKHWPESHWV
QLIELVQPTGLKIKLPWGAEHEHQRALRLAEHFPHVEVLPKLSLQQVAEV
LAGAKAVVSVDTGLSHLTAALDRPNITLFGPTDPGLIGGYGKNQIAVISE
QKKMDSLSAPTIMARLETLIS
>YPO0058 rfaD, ADP-L-glycero-D-manno-heptose-6-epimerase
MIIVTGGAGFIGSNIVKALNNIGYKDILVVDNLKDGTKFVNLVDLDIADY
MDKEDFVASIVAGDDMGDIDAIFHEGACSSTTEWDGKYMMDNNYQYSKDI
LHFCLDRSIPFLYASSAATYGGRTDNFIEDRQYEQPLNVYGYSKFLFDQY
VREILPQADSQICGFRYFNVYGPREGHKGSMASVAFHLNNQINAGERPKL
FAGSENFKRDFIYVGDVADVNLWFWQNGVSGIFNCGTGRAESFQAVADAV
VDYHQSGPVEYIEFPEKLKGRYQAYTQADLTKLRAAGYGKPFKTVAEGVK
EYLAWLNRSV
>YPO0654 rfaE, ADP-heptose synthase
MKVTLPDFRRAGVLVVGDVMLDRYWYGPTCRISPEAPVPVVKVDTIEERP
GGAANVAMNIASLGAVARLVGLTGIDDAARALICKLSEVRVRCDFVSVPT
HPTITKLRVLSRNQQLIRLDFEEGFDGVDPTPIFERIQLALPQIGALVLS
DYAKGALNSVQPMIQLARKANVPVLIDPKGSDFERYRGATLLTPNLSEFE
AVVGRCKNEEELVNRGMQLVADFELSALLVTRSEQGMTLLQLGKPPLHLP
TQAKEVFDVTGAGDTVIGVLAAALAAGNSLEESCFLANAAAGVVVGKLGT
STVSPIELENAIRGRAETGFGVMDEQQLKIAVAQARQRGEKVVMTNGIFD
ILHAGHVSYLANARKLGDRLIVAVNSDASTKRLKGEKRPVNPLEQRMVVL
GALEAVDWVVPFEEDTPQRLIADILPDLLVKGGDYKPHEIAGSEEVWAAG
GEVKVLNFEDGVSTTNIIQSIKNGRG
>YPO0057 rfaF, ADP-heptose--LPS heptosyltransferase II
MKILVIGPSWVGDMMMSQSLYRTLKAEYPAADIDVMAPAWCRPLLARMPE
VRHAIPMPLGHGAFAFEERRRLGLALRETEYDRAYVLPNSFKSALIPYFS
GIKRRIGWRGEMRYFLLNDLRILDKQAFPMMVQRYVALAYDKERIRSAAD
LPQPLLWPQLQVRDEEIAETTASFNLTDNRPIIGFCPGAEFGPAKRWPHY
HYATLAQKLIDDGYQVILFGSAKDNEAGEDIRQALSDTDREYCLNLAGQT
SLEQAVVLIAACSAVVSNDSGLMHVAAALNKPLVALYGPSSPDFTPPLSE
KATVIRLITGYHKVRKGDSAQGYHQSLIDIQPEHVMAALEKQLATQECSV
KGGD
>YPO3866 rfe, putative undecaprenyl-phosphate alpha-N-acetylglucosaminyltransferase
MNLLTMSTELIYIFLFSMAFLFVARKVAIKIGLVDKPNYRKRHQGLIPLV
GGISVFAGVCFAFLITNQQIPHFRLYLACAGLLVFVGALDDRFDISVKIR
AFVQALVGIAMMAVAGLYLRSLGHAFGPWEMVLGPFGYVVTLFAVWAAIN
AFNMVDGIDGLLGGLSCVSFGAMGILLYQSGQMSLALWCFAMIATIIPYI
LLNLGLLGRRYKVFMGDAGSTLIGFTAIWILLQATQGNAHPINPVTALWI
IAIPLMDMIAIMYRRLRKGMSPFSPDRQHIHHLIMRAGFTSRQAFVLITL
AAALLAMIGVIGERLTFIPEWVMLALFLLAFLLYGYCIKRAWRVARFIKR
FKRRMRRASKNKHES
>YPO3859 rffA, putative lipopolysaccharide biosynthesis protein
MIPFNTPPIVGTELGYMQAAMSSGKLCGDGGFTRRCQQWMEKRFNCPKVL
LTPSCTASLEMAALLLDIKPGDEVIMPSFTFVSTANAFVLRGAKMVFVDI
RPDTMNIDETKIEAAITDKTRVIVPVHYAGVACEMDTIMALAKKHNLFVV
EDAAQGVMSTYKGKALGTIGHIGCFSFHETKNYTAGGEGGATLINDPSLI
DRAEIIREKGTNRSQFFRGQVDKYTWRDIGSSYLMSDLQAAYLWGQLEAA
EQINERRLALWHGYYNAFKPLADAGRIDLPVIPGNVVQNAHMFYIKLRDI
EERSAFISYLKEADIMAVFHYIPLHACPAGEAFGRMAGEDRFTSKESERL
VRLPIFYNLTDVNQSTVINTVLSFFV
>YPO3863 rffD, putative UDP-glucose/GDP-mannose dehydrogenase
MSFETISVIGLGYIGLPTAAAFASRKKKVIGVDVNAHAVETINRGAIHIV
EPDLDKVVKIAVEGGYLQAVTKPQAADAFLIAVPTPFKGDHEPDMIFVES
AAKSIAPVLKKGDLVILESTSPVGATEQMAQWLAEARPDLSFPQQAGEAA
DINIAYCPERVLPGQVMVELIQNDRVIGGMTPKCSARASALYKIFLEGEC
VVTNSRTAEMCKLTENSFRDVNIAFANELSLICDEQGINVWELIRLANRH
PRVNILQPGPGVGGHCIAVDPWFIVSQNPQLARLIHTARLVNDGKPLWVV
DRVKAAVADCLAASDKRASEVKIACFGLAFKPDIDDLRESPAVGVARLIA
EWHVGETLVVEPNVEQLPKSLMGLVTLKDTATALQQADVLVMLVDHKQFK
AIKPEDIKQQWIVDTKGVWR
>YPO3864 rffE, UDP-N-acetylglucosamine 2-epimerase
MKVLTVFGTRPEAIKMAPLVHALAQDDAFESRVCVTAQHREMLDQVLRLF
EIQPDYDLDIMRPGQGLTEITCRILEGLKPVLEEFKPDVILVHGDTTTTL
SASLAGFYHRIPVGHVEAGLRTGDLYSPWPEEANRQLTGHLAMYHFAPTE
NSRQNLLREWVPENRIFVTGNTVIDALFWVRDRVMNTPDLRANLAQRYAF
LDTNKKMILVTGHRRESFGGGFERICSALAEIARKHPEVQVVYPVHLNPN
VSEPVNRILKGIDNIILIDPQDYLPFVYLMNHAYLILTDSGGIQEEAPSL
GKPVLVMRDTTERPEAVDSGTVLLVGTNINKIVDAVTRLLTDETAYHQMT
RAHNPYGDGYACQRILKALKNHQVTL
>YPO3862 rffG, dTDP-D-glucose-4,6-dehydratase
MRRILVTGGAGFIGSAVVRHIIDGTSDSVVVVDKLTYAGNLESLSVVAGS
ERYAFEQVDICDSSELDRVFAQYQPNVVMHLAAESHVDRSIDGPAAFIET
NVVGTYTLLEAARHYWQQLSVEAKQAFRFHHISTDEVYGDLHGTDDLFTE
TTPYAPSSPYSASKASSDHLVRAWLRTYGLPTLVTNCSNNYGPYHFPEKL
IPLVILNALAGKPLPVYGNGAQVRDWLYVEDHARALYQVVTEGVVGETYN
IGGHNERKNIEVVETICALLDELVPAKPAGIAHYRDLITYVKDRPGHDMR
YAIDAGKIERELGWRPQETFESGIRKTVLWYLNNESWWRRVQDGSYAGER
LGLSD
>YPO3861 rffH, glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGSRLHPITRGVSKQLLPIYDKPMIYYPLSVLMLAGIRDVL
IISTPEDLPSFQRLLGNGDEFGINLSYAAQPSPDGLAQAFIIGEAFIDNE
PCCLVLGDNIYFGQGFSPKLKAVAARQQGATVFGYQVMDPERFGVVEFDD
NFRALSIEEKPSQPKSNWAVTGLYFYDNQVVDFAKQVKPSARGELEITSI
NQMYLDRGELTVELLGRGFAWLDTGTHDSLIEASTFVQTVEKRQGFKIAC
LEEIAWRNGWLDDDGVKRAATALAKTGYGKYLLDLLHARPRQY
>YPO2602 rlpA, rare lipoprotein A precursor
MRKEWLWVGIASVLLSACIDQPPAPQQQVQQTYSGPVEEIGGAEPRYEPF
NPNVNQDYKVNGQSYRIIKDPQNFSQIGLASSYGEEARGNTTATGEIFDP
NALTAAHPTLPIPSYVRVTNVSNGRQIVVRVNDRGPYTPGRVIDLSRAAA
DRLNISNNTKVKIDFINVAPDGSLSGPGMVGTTIAKQSYALPSRPDLTSS
GMGTPMQQDAPATGAAVQAIDNSQLSGTDATQPVASQSSGFLRAPTPVPA
GVLESSEPVIDSAPVTPPVVANPGPVTTTPTSSAISGGYVVQVGALSDAQ
RAQSWQQSLSQRFGVPGKVSNSGSIYRVQLGPFSHRQQAVDLQQRLSNEA
QQQSFIVAAP
>YPO2609 rlpB, rare lipoprotein B precursor
MRHRILTLLLGLAVLVTAGCGFNLRGTTQVPTELQKLLLESSDPYGPLAR
SIRQQLRLNNVTIVDDAMRKDIPTLRIIGSSESQETVSIFRNGVAAENQL
VLHVQAQVLIPGHDIYPLQVNVFRTFFDNPLTALAKEAEAEVLRQEMREQ
AAQQLVRQLLTVHAAEVKNTQKNGDKPVSDANAAQGSTPTAVNETTLGEP
AVSTSAK
>YPO2380 sepC, insecticial toxin
MNTSLFSKTPAVTVLDNRGLSVRSIAYHRHPDSPDDTGERITHHQYDARG
FLTQSADPRLHDTGRANVKYLSDLVGNALCTVSADVGTTVALNDAAGRLF
MTVSNIDTADDDLEDRSQVVNRTWQYEGASLPGRLLSITEQVTGEAARVT
ERFTYAANTDEKKALNLVGQCVSHYDTAGLRQMDSIALTGVPLSVTRRLL
KDADNPDTVANWQGEDSSAWNDQLAADRLTTLTTADAIGAVLTTTDTKGN
VQRVVYNVAGLLSGSWLRVKGGAEQVIVQSLTYSAAGQKLREEHGNGVVT
TYTYEPETQRLTGIRTERSAGHASGTKVLQDLRYEYDPVGNVQSIRNDAE
ETRFWRNQKVVPENTYVYDSLYQLVSATGRVMVNAGQQGRSLPSATLPIE
SSAYTNYTHTYTYDTAGNLTQIRHTPATGSGHTTDITVSDRSNQGVLSTL
TTNPAEVDALFTAGGQQKQLQPGQHLIWTARNELLKVTPVVRDGDSDDRE
SYRYDGNSQRILKVSVQKTGGSTQTQRVMYLPRLELRSTASGVTETESLQ
IITVGEAGRAQVQVQVLHWEKGKPDAIDNDQLRYSYDNLIGSSTLEVDGD
GNVISMEEYYPYGGTAVWTAHSQTEADYKTIRYSGKERDATGLYYYGWRY
YQPWVGRWLSADPVGTVDGLNLYLMVGNNPTSFHDSNGLIREGQSARKLV
GEAFVHPLHMSVFERISIEENMAMSVREAGIYTILALGEGAAAKGHNILE
KTIKPGSLKAVYENKAGAALELAKNSGFIGRVGRWNASGVQGVYAYNRPS
GEDLVYPASLQDTSDNELVNAWIKHKIITPYTGDYDMHDIIKFNRGKGYV
PTAESAEETGVKDLINKGVAEVDPARPFEYTAMNVIRHGPQVNFVPYMWE
YEHDKVVSDNGYLGVVARPGPFPIAMVHQGQWTVFDDSKELFNFYKSSNT
PLPEHWQQNFIARGPGIVATPRHADVLDKRRIMH
>YPO2373 slyB, putative lipoprotein
MIKPFVAVAIAVVTLTGCANNNTLSGDVFTASQAKQVQTVSYGTLISVRP
VTIQGGDDNNVVGAIGGAVLGGFLGNAVGGGTGRSLATAAGAVAGGIAGQ
GVQGALNRTDGVQLEIRKDDGQTILVVQKQGPTQFSVGQRVMLANSGSTI
TVSPR
>YPO1275 spr, putative lipoprotein
MVKSQPILRYILRALPAVAAAVMLSACSSPQASNVNNTQTEMRAVNDKDG
LLLQASQDEFEAMVRNVDIKSKILEQYAGWKGVRYRLGGSSKRGIDCSAF
VQTTFREQFGMDLPRSTSQQQDLGKKVQRTKLRPGDLVLFRAGSTGRHVG
IYLGNDKFVHASTSAGVTISNLNDDYWNKRYRDGRRVLSSSSSS
>YPO1123 tolA, cell envelope integrity inner membrane protein TolA
MGKATEQNDKLNRAVIVSVVLHIILIALLIWGSLTQTTEMGGGGAGGEVI
DAVMVDPGAVTEQYNRQQQQQTDAKRAEQQRQKKAEQQAEELQQKQAAEQ
QRLKELEKERLQAQEDAKLAAEEQKKQVAEQQKQIAEQQKQAAEQQKIAA
AAVAKAKEEQKQAETAAAQAKAEADKIVKAQAEAQKKAEAEAKKEAAVAA
AAKKQADADAKKAVEVAEKAAADAAEKKAAADAEKKAAAAKKVAAAAEAK
KKAAAEAAASTDVDDLFGGLANAKNAPKSGSGAGAAAAGKGGGKKSGASG
ADISGYLGQITGAIQSKFYDADLYKGRTCDLRIKLAPDGLLIDVKAEGGD
PALCQAAIAAAKQAKIPKPPSTDVYEQFKNAPLVFKPQ
>YPO0663 tolC, outer membrane channel precursor protein
MQMKKLLPLLIGLSLAGFSTMSQAENLLQVYKQARDSNPDLRKAAADRDA
AYEKINEVRSPLLPQLGLSAGYTHANGFRDASNSPDSNATSGSLKLTQTI
FDMSKWRALTLQEKAAGIQDVTFQTSEQQLILNTATAYFNVLRAIDSLSY
TEAQKQSVYRQLDQTTQRFNVGLVAITDVQNARASYDTVLAAEVAARNNL
DNALESLRQITGVYYPELASLNVERLKTQRPDAVNNLLKEAEKRNLSLLS
ARLSQDLAREQIKSAETGYMPTVDLTASSSITNTRYSGGTPSSQQVNNDS
GQNQIGVQFSLPLYSGGATNSAVKQAQYNFVGASELLESAHRNMVQTLRS
SFNNISASISSINAYQQVVISNQSSLDAMEAGYQVGTRTILDVLTATTNL
YQSKQQLADARYNYLINQLNIKSALGTLNMNDLMALNAVLDKPVPTSAAA
LAPENTTRQTVTTPRAQ
>YPO2193 tonB, TonB protein
MQLIKFFSDRRLTWSLIFSIGLHGSVVAALLYVSVEQMKIQPEIEDTPLA
VTMVNIAEFAAPQPAAAAPEPVQETPAVPEETPPVLEETPPEPEELPEPV
PVPVPEPVKPKPKPVKKEVKKPEVKKTQAPPDDKPFKSDEAALVANNAPV
KSAPVASTPGLSTSAGPKALSKAKPSYPARALALGIEGQVKVQYDIDESG
RVTNVRVLEATPRNTFEREVKQVMRKWRFEAVAAKNYVTTIVFKLDGKME
MN
>YPO2743 vacJ, VacJ lipoprotein
MNFRLTGLAFASVLLVGCASSSPDHMEQGRSDPLEGFNRAMFNFNYEVLD
PYVVRPVAVVWRDYVPQPARNGMSNFLGNLEEPASMVNSFLVGDPYNAMK
HFNRFFLNTVLGMGGLIDVAGMANPKLAKQVPQRFGSTLGHYDVGYGPYV
VLPGYGSFTLREDGGQLADTVYPVLSYLTFWMAAGKWVLEGVETRAQLLD
SDGLVRNSSDPYLMIREAYFQRHDFLANGGQLKPEVNSNAQAIQGDLDSI
DAAD
>YPO3107 wbyJ, putative mannosyltransferase
MILRKFFIICDTVYPDDSGGRKLSLGRIFEAKESGFKVSVLHYNYTNSDV
SIARQFFLEHNIDYFYYIPAFSHKKSNLVRCANYISSVIKLTPEPYYYIM
KDYGFKKFVLDNFEMSKNSTLSIESILLSGLLPWFNTFEGSIELVFHNVE
SDFYRQLSISSRSIIYKIFFFIESMKLSAIEKYLFNIKDENIYFVFLSEK
DLEKYRLIFPEFQADIFINKNNLFIKEKIKRSVNFNKPFFLFPGGLNFPP
NRYSLNWFLAAMSKRVSSLGVDILVTGSFNDDIKSQFSQYSCVKLVGYVS
DIQLRELQSSCIAVISPIITGGGVKIKNIEAIKLKIPLIATKFSCEGIDE
RGANIYITDDEPGSFYITMKSVLNKTMSYK
>YPO3104 wbyK, putative mannosyltransferase
MKIIYDGIINSLQNMGGVTVYFSELVSRLPATDFYWYSYADEISGFGVGN
VKIKSRLLERYRNFSLDTINYNSLSVFHSSYYRLPDFDIPIVTTVHDFTY
EKFVNGPAKWVHSWQKNRAVNNSDLIICVSENTAKDLQMYCSVPSNKIRV
IYNGVSDKYHYIKGVKITTNKVIFVGARGGYKNFDIAVKAISKTPHLELS
VVGGGAFTSKELSLLNHYLPGRYHGLGRLSDEALNEAYNSAYALLYPSSY
EGFGIPILEAMSAGCPVISVNVSSIPEVAGDAAILVQKPTIDELVDGLLA
VESERSKLIGYGMKQAAKFSWDKCYQETLDVYKELNK
>YPO3098 wbyL, probable glycosyltransferase
MKISIITATYNSERTISDTLSSLEKQTYLDVEYIIVDGASKDNTLTVISQ
NSTRVTKIISESDQGIYDALNKGIDLATGDIIGFLHSDDLLAYPGALSDI
VETFEKQQCDAVYGDLQYVAKNDLNKVIRCWKSGFFNHEKMKYGWMPPHP
TFYMKRDLYIRFGGFDLSYKISADYDSLTRYIINYKIKIAYLPKVIIKMR
VGGISNRSLGSMLLKSKEDIQIMKLRGLFWPMSFLCKNLSKLPQFLK
>YPO3855 wecG, putative UDP-N-acetyl-D-mannosaminuronic acid transferase
MEPNTVIPKYNVRGFEIWGFRDMAQVLDHLLGSGPVKTGTLVAMNAEKLL
KAEDDTALCELIKNAEYLYADGISMVRAIRRKYPQAELSRVAGADLWEAL
MQRAGQQGTPVFLVGGKPDVLAETEAKLRAQWNVNLVGSQDGYFTPEQRE
ALFARIAASGAAIVTVAMGSPKQEIFMRDCRKFYPDALYMGVGGTYDVFT
SHVKRAPKIWQNMGLEWLYRLLAQPSRIRRQLKLLKFVGYYYSGRL
>YPO3096 wzz, O-antigen chain length determinant
MSNKQARSNLDSPIPNNYDFSNVSSSRNEIDLFEIFSVVFKSKFKIILIT
LFFLISGLVVSYILPQKWTSTAIIALPGDEQVQVLDELITNLTVLDIKVD
VSANYLLSTFKQNFDSQDLREQYLVNTNYFKRLMKNNPEDGLDKRALIER
IVNENISSVNPLKDKTEGENEYRYYKLSYSASTPTDARDLLQGSINYVNT
IVNADVFRKIQRAVDLAKGIGTDKYSMELLKARNNQKVKIERLRYASSIA
DAAGVKKPVYSNGSAISDDPDFPITMGSDALNRKLEIEKSVIDLASINTE
LLNRKLYLDKLNRLEIPNVNIVPFKYLQQPTEPTKRDVPKRALIVILFAL
VGLMGSVGFVLVEHFVRERKREEEGLKLSQTKE
>YPO3865 wzzE, putative lipopolysaccharide biosynthesis protein
MSTDKTGSTNNEPSVDNELDIRGLCRTLWRGKVWIIGMAIIFAAIALGVS
YLVKQQWSATAITDKPTVNNLGGYYSQQQFLRNLDIRLNSGLVSEQPGIS
DEAYGEFITQLAAYDTRRDFWLQSDYYKQRLEGDAKADAALLDELVNNIV
FTARDDKKIPNDSIKLTAETASDANKLLRGYIDFASQRASSHLNDEIQGA
WAARTQSMKAQVKRQEAVAQAVFDREVAAVKQALKVAGQQGITSSQTDTP
AEQLADSKMFMLGKPMLEARLETLLATGPSFDIDYDQNRAMLATLNVGPT
LDDKFQTYRYLRTPEDPVTRDSPRRVFLLIMWGAIGALVGAGVVLVRRSS
KAL
>YPO2796 yapC, putaive autotransporter protein
MDKTLLAGAISLSLVILPVQVLAFTPNVVGITVNDEVVIHGIQNVRDGGV
INNGLVSDNAAITVTNGSSAGTANNTTVGDKGWLQITGALATGTIVNQGG
LLDTKTAGTVIDSQINDGGHMTLGLNSQSKGYLNIAAGAELFVTNNDPYI
SDVTTHNPALPANVMIENLNVAGLVEIGPSWKGTSIVPLPLSDVLGPVLV
TRINNVTLQGGDINLMAYSAGGQFNRLEIENLSGQGNFAMTTQLASNTGD
FITVSQQATGQFGITVQDSGKEPQSADNLALVHINRGDAQFRLLNTGGVV
DLGVYQYGLYSQESNGSTDWYLATSTEELPGTTPNVTAPMLSSAAQGVLN
MAAAPRHILNAELSTLRQRQGELKADAEGTVGVWARYLTDDSRLSDNKNI
AFKNTLSGMEIGADKQLGLNRGNMLIGAFTSYSSSDVKSTHDANGDIRSY
GGGLYLTYLDQSGFYVDTVLKANRFNNKMNTQETRGEYNQNALTTSVESG
YQWPVYANLVLEPYGKVSYSRIGSADYTLSNGMVAEVAKADSVQGELGTV
LAASYSINQMTIKPYIKLAITREFTKSNAVAINNIGFDNDFSGNVGKYGV
GINATVANNTAIFAEVDYLNGSKIETPVTANIGFRLRF